<SEC-DOCUMENT>0001104659-24-043762.txt : 20240405
<SEC-HEADER>0001104659-24-043762.hdr.sgml : 20240405
<ACCEPTANCE-DATETIME>20240404204702
ACCESSION NUMBER:		0001104659-24-043762
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240402
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240405
DATE AS OF CHANGE:		20240404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astrana Health, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		24824510

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apollo Medical Holdings, Inc.
		DATE OF NAME CHANGE:	20080715

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2410938d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:AMEH="http://apollomed.net/20240402">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_AMEH_apollomed.net_20240402 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20240402_20240402 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001083446 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001083446</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ameh-20240402.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-02</xbrli:startDate>
        <xbrli:endDate>2024-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_906_edei--DocumentType_c20240402__20240402_z7ynsGR98Xmd"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)
of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported): <b><span id="xdx_905_edei--DocumentPeriodEndDate_c20240402__20240402_z2I5IcXUiPga"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April
2, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20240402__20240402_zsrS2EJtVyhc"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000011" name="dei:EntityRegistrantName">ASTRANA HEALTH, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20240402__20240402_zfExPY5ehrue"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityFileNumber_c20240402__20240402_z1hdQA97nuhd"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000013" name="dei:EntityFileNumber">001-37392</ix:nonNumeric></span></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20240402__20240402_zX0CYMIg6iZc"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">95-4472349</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission </span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90B_edei--EntityAddressAddressLine1_c20240402__20240402_z073sBC1q8p2"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000015" name="dei:EntityAddressAddressLine1">1668 S. Garfield Avenue</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20240402__20240402_zBLFTv07JJ38"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000016" name="dei:EntityAddressAddressLine2">2nd Floor</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressCityOrTown_c20240402__20240402_zOD99xWRpxBg"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000017" name="dei:EntityAddressCityOrTown">Alhambra</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20240402__20240402_zFLEehEo9cLa"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20240402__20240402_z61WK3WYjUSd"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000019" name="dei:EntityAddressPostalZipCode">91801</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<span id="xdx_908_edei--CityAreaCode_c20240402__20240402_z2NOD0eMoRKb"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000020" name="dei:CityAreaCode">626</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20240402__20240402_zZf5fXS9JVpd"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000021" name="dei:LocalPhoneNumber">282-0288</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_901_edei--WrittenCommunications_c20240402__20240402_zQxna4mPX2Gl"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20240402__20240402_z7VuPBD4SZIe"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20240402__20240402_zlklG72IW6Ef"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20240402__20240402_znV64vMVuHtf"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="border: Black 1pt solid; padding-top: 1pt; width: 50%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--Security12bTitle_c20240402__20240402_zbfs14qNzMr9"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20240402__20240402_zeztIZgKAqCl"><ix:nonNumeric contextRef="AsOf2024-04-02" id="Fact000027" name="dei:TradingSymbol">ASTH</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--SecurityExchangeName_c20240402__20240402_ze85n4J08b7e"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20240402__20240402_zzV2dWdLa9I6"><ix:nonNumeric contextRef="AsOf2024-04-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><b>Item 5.02</b></td>
    <td style="width: 90%; font-size: 10pt; text-align: justify"><span style="background-color: white"><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b></span><b>.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Amendment and Restatement of Executive Employment Agreements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 2, 2024, Astrana Health, Inc. (the &#8220;Company&#8221;)
entered into amended and restated Employment Agreements with the Company&#8217;s Chief Executive Officer and President, Brandon Sim, and
with the Company&#8217;s Chief Operating Officer and Chief Financial Officer, Chandan Basho (as amended and restated, the &#8220;CEO Agreement&#8221;
and the &#8220;COO/CFO Agreement&#8221;, respectively). Each of the CEO Agreement and the COO/CFO Agreement amends, restates and supersedes
in its entirety the respective employment agreement that was originally entered into between the applicable executive and Astrana Health
Management, Inc. (formerly known as Network Medical Management, Inc.) effective on June 8, 2020 (for Brandon Sim) or April 12, 2022 (for
Chandan Basho).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A description of the material terms of each of
the CEO Agreement and the COO/CFO Agreement is set forth below. The following descriptions of the CEO Agreement and the COO/CFO Agreement
do not purport to be complete and are subject to, and qualified in their entirety by reference to, the complete text of the CEO Agreement
and the COO/CFO Agreement, copies of which are attached hereto as <a href="tm2410938d1_ex10-1.htm" style="-sec-extract: exhibit">Exhibit 10.1</a> and <a href="tm2410938d1_ex10-2.htm" style="-sec-extract: exhibit">Exhibit 10.2</a>, respectively, and are incorporated herein
by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>CEO Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the CEO Agreement, Brandon Sim
is entitled to receive an annual base salary of $850,000 and an annual cash bonus with a target bonus opportunity of 125% of his annual
base salary, with terms and conditions determined by the Board of Directors of the Company (the &#8220;Board&#8221;) in its discretion,
consistent with the terms of the Company&#8217;s business plan. The CEO Agreement has an initial term of three years ending on April 2,
2027, and will automatically renew for successive one-year terms on each annual anniversary thereafter, unless either party provides written
notice of intent not to renew at least 60 days prior to that date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Sim also may be eligible to participate in
any long-term incentive plan that may be available to similarly positioned executives, including any long-term incentive awards in cash
or in equity awards, with any equity awards to be granted according to the latest equity incentive plan approved by the Board and the
stockholders of the Company. In the event that Mr. Sim resigns for &#8220;Good Reason&#8221; (as defined in the CEO Agreement), the Company
terminates his employment without &#8220;Cause&#8221; (as defined in the CEO Agreement), or Mr. Sim&#8217;s employment terminates on account
of death or &#8220;Disability&#8221; (as defined in the CEO Agreement), Mr. Sim will be 100% vested with respect to any outstanding long-term
incentive awards (subject to the actual achievement of any applicable performance goals for long-term incentive awards subject to corporate
or business performance goals).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, Mr. Sim is eligible for paid time off in accordance with the Company&#8217;s paid time off policy and is entitled to participate in the employee benefit plans
offered by the Company to its employees. At a minimum, Mr. Sim&#8217;s&#160;benefits will include: (i) Company-paid premiums for medical,
dental and vision care coverage; (ii)&#160;Company-paid insurance premiums for short-term and long-term disability insurance, providing
for no less than 60% of Mr. Sim&#8217;s annual base salary, to be payable to Mr. Sim as long as the covered disability persists in a manner
that substantially prevents employment in the same occupation as the position Mr. Sim last held with the Company, but not beyond age 65;
and (iii) Company-paid insurance premiums for term life insurance providing for no less than $2.0 million of coverage (subject to meeting
applicable underwriting requirements). Mr. Sim will also be covered as a named insured within the directors and officers&#8217; insurance
policy of the Company and its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Mr. Sim&#8217;s employment ends for any reason,
Mr. Sim will be entitled to any earned but unpaid base salary or annual bonus for service rendered through the date of termination, unpaid
expense reimbursements, and any accrued but unused paid time off.&#160;Additionally, if Mr. Sim&#8217;s employment is terminated by the
Company without Cause or if Mr. Sim resigns for Good Reason, then, subject to Mr. Sim entering into and not revoking a waiver and release
of claims in favor of the Company, he will be entitled to receive (i) one year of annual base salary, or two years of annual base salary,
if Mr. Sim&#8217;s termination occurs within two years following a &#8220;Change of Control&#8221; (as defined in the CEO Agreement);
and (ii)&#160;subject to Mr. Sim&#8217;s election of continued coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985
as amended (&#8220;COBRA&#8221;), an amount in cash equal to the Company&#8217;s premium amounts paid for Mr. Sim&#8217;s coverage under
the Company&#8217;s group medical, dental and vision programs for a period of 12 months, or a period of 24 months, if Mr. Sim&#8217;s
termination occurs within two years following a Change of Control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CEO Agreement provides for customary restrictions
on (i) disclosure of confidential information while employed and perpetually thereafter, and (ii) engaging in restricted activities, such
as taking any action or engaging in any unfair business practice, including any misappropriation of confidential, proprietary or trade
secret information of the Company or its affiliates, while employed and for a period of 12 months following termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>COO/CFO Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the COO/CFO Agreement, Chandan
Basho is entitled to receive an annual base salary of $600,000 and an annual cash bonus with a target bonus opportunity of 80% of his
annual base salary, with terms and conditions determined by the Board in its discretion, consistent with the terms of the Company&#8217;s
business plan. The COO/CFO Agreement has an initial term of three years ending on April 2, 2027, and will automatically renew for successive
one-year terms on each annual anniversary thereafter, unless either party provides written notice of intent not to renew at least 60 days
prior to that date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Basho also may be eligible to participate in
any long-term incentive plan that may be available to similarly positioned executives, including any long-term incentive awards in cash
or in equity awards, with any equity awards to be granted according to the latest equity incentive plan approved by the Board and the
stockholders of the Company. In the event that Mr. Basho resigns for &#8220;Good Reason&#8221; (as defined in the COO/CFO Agreement),
the Company terminates his employment without &#8220;Cause&#8221; (as defined in the COO/CFO Agreement), or Mr. Basho&#8217;s employment
terminates on account of death or &#8220;Disability&#8221; (as defined in the COO/CFO Agreement), Mr. Basho will be 100% vested with respect
to any outstanding long-term incentive awards (subject to the actual achievement of any applicable performance goals for long-term incentive
awards subject to corporate or business performance goals).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, Mr. Basho
is eligible for paid time off in accordance with the Company&#8217;s paid time off policy and is entitled to participate in the
employee benefit plans offered by the Company to its employees. At a minimum, Mr. Basho&#8217;s&#160;benefits will include: (i)
Company-paid premiums for medical, dental and vision care coverage; (ii)&#160;Company-paid insurance premiums for short-term and
long-term disability insurance, providing for no less than 60% of Mr. Basho&#8217;s annual base salary, to be payable to Mr. Basho
as long as the covered disability persists in a manner that substantially prevents employment in the same occupation as the position
Mr. Basho last held with the Company, but not beyond age 65; and (iii) Company-paid insurance premiums for term life insurance
providing for no less than $2.0 million of coverage (subject to meeting applicable underwriting requirements). Mr. Basho will also
be covered as a named insured within the directors and officers&#8217; insurance policy of the Company and its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Mr. Basho&#8217;s employment ends for any reason,
Mr. Basho will be entitled to any earned but unpaid base salary or annual bonus for service rendered through the date of termination,
unpaid expense reimbursements, and any accrued but unused paid time off.&#160;Additionally, if Mr. Basho&#8217;s employment is terminated
by the Company without Cause or if Mr. Basho resigns for Good Reason, then, subject to Mr. Sim entering into and not revoking a waiver
and release of claims in favor of the Company, he will be entitled to receive (i) one year of annual base salary, or two years of annual
base salary, if Mr. Basho&#8217;s termination occurs within two years following a &#8220;Change of Control&#8221; (as defined in the COO/CFO
Agreement); and (ii)&#160;subject to Mr. Basho&#8217;s election of continued coverage under COBRA, an amount in cash equal to the Company&#8217;s
premium amounts paid for Mr. Basho&#8217;s coverage under the Company&#8217;s group medical, dental and vision programs for a period of
12 months, or a period of 24 months, if Mr. Basho&#8217;s termination occurs within two years following a Change of Control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The COO/CFO Agreement provides for customary restrictions
on (i) disclosure of confidential information while employed and perpetually thereafter, and (ii) engaging in restricted activities, such
as taking any action or engaging in any unfair business practice, including any misappropriation of confidential, proprietary or trade
secret information of the Company or its affiliates, while employed and for a period of 12 months following termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Long-Term Equity Incentive Awards</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 2, 2024, the Company granted long-term
equity incentive awards to its Chief Executive Officer and President, Brandon Sim, and its Chief Operating Officer and Chief Financial
Officer, Chandan Basho. The total grant date value of these awards was $11,000,000 and $2,000,000, respectively, with 33% of each grantee&#8217;s
total grant date value was allocated to time-based restricted stock units and 67% of each grantee&#8217;s total grant date value was allocated
to performance-based restricted stock units. The time-based restricted stock units granted to Messrs. Sim and Basho will vest, subject
to continued employment or other service, in eight equal semi-annual installments over the four-year period, with vesting beginning on
the six month anniversary of the grant date. The performance-based restricted stock units granted to Messrs. Sim and Basho will vest based
on the level of achievement of pre-determined adjusted EBITDA and revenue performance over the three year performance period beginning
January 1, 2024 and ending December 31, 2026, subject to continued employment or other service until the date of the Compensation Committee&#8217;s
certification of the achievement of such performance goals following the end of the performance period. The time-based restricted stock
units were granted pursuant to the Company&#8217;s 2015 Equity Incentive Plan, and the performance-based restricted stock units were granted
pursuant to the Company&#8217;s 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;), subject to and conditioned upon the approval
of the 2024 Plan by the Company&#8217;s stockholders at the 2024 Annual Meeting of Stockholders. The time-based and performance-based
restricted stock units granted to Messrs. Sim and Basho are subject to the terms of restricted stock unit award agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><b>Item 9.01</b></td>
    <td style="width: 90%; font-size: 10pt; text-align: justify"><b>Financial Statements and Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 10%"><b>Exhibit No.</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 88%"><b>Description of Exhibit</b></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="vertical-align: top; text-align: center"><a href="tm2410938d1_ex10-1.htm" style="-sec-extract: exhibit">10.1*</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm2410938d1_ex10-1.htm" style="-sec-extract: exhibit">Employment Agreement between Astrana Health, Inc. and Brandon Sim (Amended and Restated as of April 2, 2024). </a></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><a href="tm2410938d1_ex10-2.htm" style="-sec-extract: exhibit">10.2*</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm2410938d1_ex10-2.htm" style="-sec-extract: exhibit">Employment Agreement between Astrana Health, Inc. and Chandan Basho (Amended and Restated as of April 2, 2024). </a></td></tr>
  <tr style="background-color: #CCECFF">
    <td style="vertical-align: top; text-align: center">104</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Management contract or compensatory plan, contract or arrangement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom"><b>ASTRANA HEALTH, INC. </b></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%">Date: April 4, 2024</td>
    <td style="vertical-align: bottom; width: 5%">By: </td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 45%">/s/ Brandon Sim</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">Name:</td>
    <td style="vertical-align: top">Brandon Sim</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">Title:</td>
    <td style="vertical-align: bottom">Chief Executive Officer and President</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LppGBembFi1iFSkivga7SrDNlk38O5K3NLaIy8KyzHwzQsQip6WpkeE4LwvYY9PW2iOUeEZGe8LgyFbrFMIt8WKcZ2199/7AjAKDgZkMlNJB6Kx347BKQY6HcjRUY5BJmkxhthHRV8/Ink2F1htdg7YV7JhaNug1v/qEvX6SpebVVR2QnSGbQjKQvfwGJRMFW7rrB/HVQVFkIoq7iUTOdGuDa/H0aL8kLGpsQp3r6f9GH/u4Sno= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2410938d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amended and Restated as of April 2, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>EMPLOYMENT AGREEMENT
</B>(this &ldquo;<U>Agreement</U>&rdquo;) by and between Astrana Health, Inc., a Delaware corporation (the &ldquo;<U>Employer</U>&rdquo;),
and Brandon Sim (the &ldquo;<U>Employee</U>,&rdquo; and together with the Employer, collectively referred to as the &ldquo;<U>Parties</U>&rdquo;),
amends and restates and supersedes in its entirety, effective as of April 2, 2024 (the &ldquo;<U>Restatement Date</U>&rdquo;), that certain
Employment Agreement by and between Astrana Health Management, Inc. (formerly known as Network Medical Management, Inc.) and the Employee
that originally became effective on June 8, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Employer desires
to continue to employ the Employee on the terms and conditions set forth below, and the Employee is willing to serve the Employer on such
terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Engagement and Duties</U>. Employer shall continue to employ the Employee as Chief Executive Officer and President during the
Term of this Agreement, to perform the duties customarily associated with such offices and such other duties as may be assigned to the
Employee from time to time by the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) of Astrana Health, Inc. (formerly known as Apollo
Medical Holdings, Inc.) (&ldquo;<U>Astrana Health</U>&rdquo;). Employee hereby accepts such employment by Employer upon the terms and
subject to conditions set forth in this Agreement. Employee shall report to the Board. Employee shall devote his best efforts, skills
and abilities, on a full-time basis, exclusively to the Employer&rsquo;s business. Employee covenants and agrees to faithfully adhere
to and fulfill such policies as are established from time to time by the Board or the Employer (&ldquo;<U>Policies</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Performance of Services for Affiliates</U>. In addition to the performance of services for Employer, Employee shall, to the
extent so required by Employer, also perform services for its &ldquo;Affiliates&rdquo; (as defined in <U>Section 6</U> below), provided
that such services are consistent with the kind of services Employee performs or may be required to perform for Employer under this Agreement.
If Employee performs any services for any Affiliate, Employee shall not be entitled to receive any compensation or remuneration in addition
to or in lieu of the compensation and remuneration provided under this Agreement on account of such services for the Affiliate. The Policies
will govern Employee&rsquo;s employment by Employer and its Affiliates for which Employee is asked to provide services. In addition, Employee
covenants and agrees that Employee will faithfully adhere to and fulfill such additional policies as may be established from time to time
by the board of directors of any Affiliate for which Employee performs services, to the extent that such policies and procedures differ
from or are in addition to the Policies adopted by Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Conflicting Obligations</U>. Employee represents and warrants to Employer that Employee is under no obligations or commitments, whether
contractual or otherwise, that are inconsistent with Employee&rsquo;s obligations under this Agreement or that would prohibit Employee,
contractually or otherwise, from performing Employee&rsquo;s duties under this Agreement and the Policies; provided, however, that Employee
may participate as a member of the board of directors or advisory board of other entities and in professional organizations and civic
and charitable organizations, so long as any such positions are disclosed to the Board and do not materially interfere with the Employee&rsquo;s
responsibilities and duties to the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>No Unauthorized Use of Third-Party Intellectual Property</U>. Employee represents and warrants to Employer that Employee will
not use or disclose, in connection with Employee&rsquo;s employment by Employer or any Affiliate, any patents, trade secrets, confidential
information, or other proprietary information or intellectual property as to which any other person has any right, title or interest,
except to the extent that Employer or its Affiliate holds a valid license or other written permission for such use from the owner(s) thereof.
Employee represents and warrants to Employer that Employee has returned all property and confidential information belonging to any prior
employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
The initial term of this Agreement, as amended and restated, shall be for a three (3) year period commencing on the Restatement Date.
The term of this Agreement shall automatically renew for an additional year on each applicable anniversary of the Restatement Date unless
either Party gives the other written notice of intent not to renew at least sixty (60) days prior to such date. Notwithstanding the foregoing,
the initial term and any renewal year shall be subject to earlier termination as provided in&#8239;<U>Section 4</U>&#8239;below. The initial
term and any renewal years are referred to herein as the &ldquo;<U>Term</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
and Related Matters</U>. The Employer shall provide the Employee with the compensation and benefits set forth in this <U>Section 3</U>
during the Term. Authority to take action under this Section 3 with respect to the Employee&rsquo;s compensation and benefits may be delegated
by the Board to its compensation committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Base Salary</U>. The Employer shall pay the Employee, as an exempt employee, for all services rendered a base salary of $850,000
per year (the &ldquo;<U>Base Salary</U>&rdquo;), payable, bi-weekly, and in accordance with the Employer&rsquo;s payroll procedures, subject
to customary withholdings and employment taxes. The Base Salary shall be evaluated at least annually by the Board for increase only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Annual Bonus</U>. In the Employer&rsquo;s sole discretion, the Employee is eligible to receive an annual cash bonus (the &ldquo;<U>Annual
Bonus</U>&rdquo;) with a target Annual Bonus opportunity of 125% of the Employee&rsquo;s Base Salary for each fiscal year during the Term
on such terms and conditions as the Board shall determine in its discretion consistent with the terms of the Employer&rsquo;s business
plan. The target Annual Bonus opportunity (as a percentage of Base Salary) shall be evaluated at least annually by the Board for increase
only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Long Term Incentive Awards</U>. In the Employer&rsquo;s sole discretion, the Employee may be eligible to participate in any
long term incentive plan that may be available to similarly positioned executives. The Board may determine to grant long-term incentive
awards in cash or in equity awards settled in shares of the Employer&rsquo;s or its Affiliates&rsquo; stock, including but not limited
to stock options, restricted stock and performance shares. Any equity or options will be granted according to the latest Equity Incentive
Plan approved by the Board and the stockholders of Astrana Health. A &ldquo;<U>No Fault Separation</U>&rdquo; means that, during the Term,
either the Employee has resigned for Good Reason (as defined in <U>Section 4(e)</U> below), the Employer has terminated the Employee&rsquo;s
employment without Cause (as defined in <U>Section 4(d)</U> below or the Employee terminates employment on account of death or Disability
(as defined in <U>Sections 4(a) &amp; (b)</U> below). In the event the Employee terminates service due to a No Fault Separation, any requirements
under any long-term incentive award held by the Employee shall be deemed to have been satisfied by the Employer immediately prior to such
termination. For avoidance of doubt, a No Fault Separation entitles the Employee to be 100% vested with respect to any stock options with
vesting conditions based solely on continued employment, and to be entitled to payment with respect to any long-term incentive award subject
to corporate or business goals to the extent that such goals are met during the performance period on the same basis as if he had remained
continuously employed with the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Paid Time Off</U>. During the Term, the Employee will be eligible for paid time off in accordance with and subject
to all of the terms and conditions of the Employer&rsquo;s Paid Time Off policy (which such policy is compliant with CA&rsquo;s Paid Sick
Leave requirements, to the extent applicable), as such policy may be amended from time to time in the Employer&rsquo;s sole discretion.
Employee will also be eligible for paid holidays, in accordance with and subject to all of the terms and conditions of the Employer&rsquo;s
policies, as such policies may be amended from time to time or terminated in the Employer&rsquo;s sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Expenses</U>. The Employee shall be entitled to prompt reimbursement of reasonable and usual business expenses incurred on behalf
of Employer in accordance with the Employer&rsquo;s expense reimbursement policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Benefits</U>. The Employee shall be entitled to continue to participate in or receive benefits under any employee benefit plan
or arrangement which is or may, in the future, be made available by the Employer to its employees, subject to and on a basis consistent
with the terms, conditions and overall administration of such plan or arrangement. Irrespective of other benefits provided to employees,
the Employee&rsquo;s benefits package shall include: (i) the Employer&rsquo;s payment of premiums for medical, dental and vision care
coverage; (ii) the Employer&rsquo;s payment of insurance premiums for short-term and long-term disability insurance providing for no less
than sixty percent (60%) of Employee&rsquo;s Base Salary to be payable to the Employee as long as the covered disability persists in a
manner that substantially prevents employment in the same occupation as the position Employee last held with Employer but not beyond age
sixty-five (65); and (iii) the Employer&rsquo;s payment of insurance premiums for term life insurance providing for no less than two million
dollars of coverage (subject to meeting applicable underwriting requirements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Tax Withholding.</U> The Employer shall undertake to make deductions, withholdings and tax reports with respect to payments
and benefits under this Agreement, to the extent it reasonably and in good faith believes it is required to make such deductions, withholdings
and tax reports. Payments with respect to compensation and benefits referred to under this Agreement shall be in amounts net of any such
deductions or withholdings. Nothing in this Agreement shall be construed to require the Employer to make any payments to compensate the
Employee for any adverse tax effect associated with any payments or benefits, or for any deduction or withholding from any payment or
benefit. Employee will be solely responsible for and will satisfy all of Employee&rsquo;s tax obligations associated with all compensation
paid or provided to Employee under this Employment Agreement. Employee acknowledges and agrees that Employee is not relying on any advice
from the Employer or any Employer affiliate, officer, director, employee, agent or attorney with respect to any tax issue relating to
this Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Directors And Officers Insurance</U>. Employee will be covered as a named insured within the Directors and Officers insurance
policy of the Employer and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
The Employee&rsquo;s employment hereunder may be terminated during the Term without any breach of this Agreement under the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Death</U>. The Employee&rsquo;s employment hereunder shall terminate upon the Employee&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Disability</U>. The Employer may terminate the Employee&rsquo;s employment if the Employee is disabled for 90 or more consecutive
days and, because of the disability, is unable to perform the essential functions of the Employee&rsquo;s then existing position or positions
under this Agreement with or without reasonable accommodation. This provision is not intended to reduce any rights the Employee may have
pursuant to any law, including without limitation (and to the extent applicable) the California Family Rights Act, the Family and Medical
Leave Act, the California Fair Employment and Housing Act, and the Americans with Disabilities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Termination by the Employer for Cause</U>. At any time during the Term, the Employer may terminate the Employee&rsquo;s employment
hereunder for Cause. For purposes of this Agreement, &ldquo;<U>Cause</U>&rdquo; shall mean: (i) conduct by the Employee constituting a
material act of willful misconduct in connection with the performance of the Employee&rsquo;s duties that results in loss, damage or injury
that is material to the Employer; (ii) the Employee&rsquo;s conviction of, or plea of guilty or nolo contendere to, any felony; (iii)
continued, willful and deliberate non-performance by the Employee of the Employee&rsquo;s duties hereunder (other than by reason of the
Employee&rsquo;s physical or mental illness, incapacity or disability); (iv) a material breach by the Employee of&#8239;<U>Section 6</U>&#8239;of
this Agreement that results in loss, damage or injury that is material to the Employer; (v) willful failure to cooperate with a bona fide
internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Employer to cooperate,
or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the willful
inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigations; or (vi) fraud,
embezzlement or theft against the Employer or any of its Affiliates (as defined in&#8239;<U>Section 6(a)</U>&#8239;below). With respect
to the events in (i), (iii) and (iv) herein, the Employer shall have delivered written notice to the Employee of its intention to terminate
the Employee&rsquo;s employment for Cause, which notice specifies in reasonable detail the circumstances claimed to give rise to the Employer&rsquo;s
right to terminate the Employee&rsquo;s employment for Cause and the Employee shall not have cured such circumstances to the extent such
circumstances are reasonably susceptible to cure as determined by the Board in good faith within sixty (60) days following the Employer&rsquo;s
delivery of such notice. For avoidance of doubt, &ldquo;Cause&rdquo; shall not include (x) expense reimbursement disputes in which the
Employee acts in reasonable good faith; (y) occasional, customary and de minimis use of the Employer&rsquo;s property for personal purposes;
and (z) acting in good faith upon advice of Employer&rsquo;s legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Termination by Employer without Cause</U>. At any time during the Term, the Employer may terminate the Employee&rsquo;s employment
hereunder without Cause by providing the Employee with sixty (60) days advance written notice. Any termination by the Employer of the
Employee&rsquo;s employment under this Agreement that does not constitute a termination for Cause under <U>Section 4(c)</U> and does not
result from the death or Disability of the Employee under <U>Sections 4(a)</U> or <U>4(b)</U> shall be deemed a termination without Cause
under this <U>Section 4(d)</U>. Any suspension of the Employee&rsquo;s employment with pay or benefits by the Board in good faith pending
an investigation of alleged improper activities by the Employee that, if determined to be accurate, would be grounds for a Cause termination,
shall not be considered a termination of the Employee&rsquo;s employment without Cause or provide with Good Reason to terminate employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Termination by the Employee</U>. At any time during the Term, the Employee may terminate his employment hereunder for any reason,
including, but not limited to, Good Reason. For purposes of this Agreement, &ldquo;<U>Good Reason</U>&rdquo; shall mean that the Employee
has complied with the &ldquo;<U>Good Reason Process</U>&rdquo; (hereinafter defined) following the occurrence of any of the following
events without the Employee&rsquo;s written consent: (i) a reduction in the Employee&rsquo;s Base Salary; (ii) a diminution in the Employee&rsquo;s
responsibilities, authority or duties (including, without limitation, a requirement that the Employee report to any person other than
the Board); or (iii) the material breach of this Agreement by the Employer, including but not limited to a failure to pay Base Salary
or Annual Bonus when due under this Agreement; or (iv) Chandan Basho is no longer part of the management team of Astrana Health or one
of its wholly owned subsidiaries. &ldquo;<U>Good Reason Process</U>&rdquo; shall mean (A) the Employee reasonably determines in good faith
that a &ldquo;Good Reason&rdquo; condition has occurred; (B) the Employee notifies the Employer in writing of the occurrence of the Good
Reason condition within (60) days of the occurrence of such condition; (C) the Employee cooperates in good faith with the Employer&rsquo;s
efforts, for a period of sixty (60) days following such notice (the &ldquo;<U>Cure Period</U>&rdquo;), to remedy the condition; (D) notwithstanding
such efforts, the Good Reason condition continues to exist; and (E) the Employee terminates his employment within fourteen (14) days after
the end of the Cure Period. If the Employer cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to
have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Change of Control</U>. For purposes of this Agreement, &ldquo;Change of Control&rdquo; means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
person (within the meaning Section 3(a)(9) of the Securities Exchange Act of 1934, as amended, and as used in Sections 13(d) and 14(d)
thereof, including a &ldquo;group&rdquo; as defined in Section 13(d) thereof) becomes the beneficial owner (within the meaning of Rule&#8239;13d-3
under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of Astrana Health representing more than
30% of the total voting power or value represented by Astrana Health&rsquo;s then outstanding voting securities (excluding for this purpose
any such voting securities held by Astrana Health or its subsidiaries or by any employee benefit plan of the Astrana Health or a subsidiary)
pursuant to a transaction or a series of related transactions; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
closing of either (A) A merger or consolidation of Astrana Health whether or not approved by the Board, other than a merger or consolidation
which would result in the voting securities of Astrana Health outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) more than
50% of the total voting power or value represented by the voting securities of Astrana Health or such surviving entity or parent of such
corporation, as the case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by Astrana
Health of all or substantially all of Astrana Health&rsquo;s assets; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
change in the composition of the Board, as a result of which fewer than a majority of the members of the Board are Incumbent Directors.
For this purpose, &ldquo;<U>Incumbent Directors</U>&rdquo; shall mean members of the Board who either (A)&#8239;are directors of Astrana
Health on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control, or (B)&#8239;are elected,
or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such
election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened
proxy contest relating to the election of directors of Astrana Health).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Notice of Termination</U>. Except for termination as specified in <U>Section 4(a)</U>, any termination of the Employee&rsquo;s
employment shall be communicated by written Notice of Termination by the terminating Party to the other Party hereto. For purposes of
this Agreement, a &ldquo;<U>Notice of Termination</U>&rdquo; shall mean a notice which shall indicate the specific termination provision
in this Agreement relied upon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Date of Termination</U>. &ldquo;<U>Date of Termination</U>&rdquo; shall mean the earliest of the following: (i) if the Employee&rsquo;s
employment is terminated by the Employee&rsquo;s death, the date of the Employee&rsquo;s death; (ii) if the Employee&rsquo;s employment
is terminated on account of Disability under <U>Section 4(b)</U> or by the Employer for Cause under <U>Section 4(c)</U>, the date on which
Notice of Termination is given that follows any applicable required cure period; (iii) if the Employee&rsquo;s employment is terminated
by the Employer under <U>Section 4(d)</U>, sixty (60) days after the date on which a Notice of Termination is given; (iv) if the Employee&rsquo;s
employment is terminated by the Employee under <U>Section 4(e)</U> without Good Reason, sixty (60) days after the date of which a Notice
of Termination is given or such shorter period agreed to by the Employer; or (v) if the Employee&rsquo;s employment is terminated by the
Employee under <U>Section 4(e)</U> with Good Reason, the date on which Notice of Termination is given after the end of the Cure Period.
Notwithstanding the foregoing, in the event that the Employee gives a Notice of Termination to the Employer, the Employer may unilaterally
accelerate the Date of Termination but such acceleration shall nevertheless be deemed a termination without Cause by the Employer, on
the accelerated date for purposes of this Agreement. For purposes of determining the time when the Severance Amount, is to be paid under
<U>Section 5(b)(i)</U> of this Agreement, &ldquo;<U>Date of Termination</U>&rdquo; means the Employee&rsquo;s separation from service
as defined under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
upon Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Accrued Benefits</U>. If the Employee&rsquo;s employment with the Employer is terminated for any reason during the Term, the
Employer shall pay or provide the Employee (or the Employee&rsquo;s authorized representative or estate) any earned but unpaid Base Salary
or Annual Bonus for services rendered through the Date of Termination, unpaid expense reimbursements, and accrued but unused paid time
off (the &ldquo;<U>Accrued Benefits</U>&rdquo;) within the time prescribed by applicable law. With respect to vested compensation or benefits
the Employee may have under any employee benefit or compensation plan, program or arrangement of the Employer, payment will be made to
the Employee under the terms of the applicable plan, program or arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Termination by the Employer without Cause or by the Employee with Good Reason</U>. If the Employee&rsquo;s employment is terminated
by the Employer without Cause as provided in Section 4(d), or the Employee terminates his employment for Good Reason as provided in Section
4(e), then (x) the Employer shall, through the Date of Termination, pay the Employee his or her Accrued Benefits, and (y) if the Employee
signs a general release of claims on a form provided by the Employer for such purpose (the &ldquo;<U>Release</U>&rdquo;) within twenty-one
(21) days of the receipt of the form of the Release (extended to forty-five (45) days in the event of a group termination or exit incentive
program) and does not revoke such Release during the seven-day revocation period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>the Employer shall pay the Employee an amount equal to one (1) year of the Employee&rsquo;s most recent Base Salary, if such termination
occurs outside of the Change of Control Protection Period, or two (2) years of the Employee&rsquo;s most recent Base Salary, if such termination
occurs during the Change of Control Protection Period (but in any case determined prior to any action involving Base Salary that would
constitute Good Reason) (the &ldquo;<U>Severance Amount</U>&rdquo;), subject to such payroll deductions and withholdings as are required
by law. The Severance Amount shall be paid in substantially equal amounts on each payroll date over a one-year period, if such termination
occurs outside of the Change of Control Protection Period, or over a two-year period, if such termination occurs during the Change of
Control Protection Period, in either case commencing as soon as practicable after the Release becomes effective and irrevocable in accordance
with its terms; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>the Employer shall pay the Employee an amount in cash equal to the Employer&rsquo;s premium amounts paid for coverage of Employee
at the time of the Employee&rsquo;s termination of coverage under the Employer&rsquo;s group medical, dental and vision programs for a
period of twelve (12) months, if such termination occurs outside of the Change of Control Protection Period, or a period of twenty-four
(24) months, if such termination occurs during the Change of Control Protection Period, to be paid directly to the Employee at the same
times such payments would be paid on behalf of a current employee for such coverage; <U>provided</U>, <U>however</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>No payments shall be made under this paragraph (ii) unless and until the Employee timely elects continued coverage under such plan(s)
pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 as amended (&ldquo;<U>COBRA</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>This paragraph (ii) shall not be read or construed as placing any restrictions upon amounts paid under this paragraph (ii) as to
their use;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Payments under this paragraph (ii) shall cease as of the earliest to occur of the following: (1) the Employee is no longer eligible
for and continuing to receive the COBRA coverage elected in subparagraph (A); (2) the time period set forth in the first sentence of this
paragraph (ii); (3) the date on which the Employee first becomes eligible to enroll in a group health plan in which eligibility is based
on employment with an employer; and (4) if the Employer in good faith determines that payments under this paragraph (ii) would result
in a discriminatory health plan pursuant to the Patient Protection and Affordable Care Act of 2010, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>For purposes of this Section 5(b), the &ldquo;Change of Control Protection Period&rdquo; means the period beginning on (and including)
the date of a Change of Control and ending on the second anniversary of such Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Each individual <U>payment</U> of Severance Amount under <U>Section 5(b)(i)</U>, and each payment under <U>Section 5(b)(ii)</U>
of this Agreement, shall be deemed to be a separate &ldquo;payment&rdquo; for purposes and within the meaning of Treasury Regulation Section
1.409A-2(b)(2)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>For each individual payment of the Severance Amount under <U>Section 5(b)(i)</U>, and each payment under <U>Section 5(b)(ii)</U>,
of this Agreement, to the extent considered &ldquo;non-qualified deferred compensation&rdquo; (&ldquo;<U>NQDC</U>&rdquo;) under Section
409A, then the Employer shall make any such payment not earlier than the earlier of: (x) the first payroll date which is six (6) months
following the Employee&rsquo;s separation from service (as defined under Section 409A) with the Employer, or (y) the date of Employee&rsquo;s
death. The Employer may in its sole discretion accelerate or defer (but not beyond the time limit set forth below) any severance payments
which do not constitute NQDC in order to allow for the payment of taxes due, but not beyond the time limit specified for such payment
such that the payment would be treated as NQDC. Further, in the event that the period in which Employee is required to provide the Release
begins in one calendar year and ends in the next calendar year, then, solely to the extent necessary to comply with Section 409A, any
payment pursuant to <U>Section 5(b)(i)</U> or <U>Section 5(b)(ii)</U> shall be made during the later calendar year. For purposes of this
Section 5, (A) &ldquo;<U>Section 409A</U>&rdquo; means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidential
Information/Competitive Activities/Intellectual Property/ Cooperation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Affiliate</U>&rdquo; means, as to any Person, (A) any other Person which directly, or indirectly through one or more
intermediaries, controls such Person or is consolidated with such Person in accordance with GAAP, (ii) any other Person which directly,
or indirectly through one or more intermediaries, is controlled by or is under common control with such Person, or (B) any other Person
of which such Person owns, directly or indirectly, fifty percent (50%) or more of the common stock or equivalent equity interests. As
used herein, the term &ldquo;control&rdquo; means possession, directly or indirectly, of the power to direct or cause the direction of
the management or policies of a Person, whether through the ownership of voting securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Person</U>&rdquo; means an individual, a corporation, a partnership, a limited liability company, an association, a trust
or any other entity or organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>&ldquo;<U>Confidential Information</U>&rdquo; means information belonging to the Employer or its Affiliates which is of value to
the Employer or any of its Affiliates in the course of conducting its business (whether having existed, now existing, or to be developed
or created during Employee&rsquo;s employment by Employer) and the disclosure of which could result in a competitive or other disadvantage
to the Employer or its Affiliates. Confidential Information includes, without limitation, contract terms and rates; negotiating and contracting
strategies; financial information, reports, and forecasts; inventions, improvements and other intellectual property; product plans or
proposed product plans; trade secrets; designs, processes or formulae; software; employee, customer, patient, provider and supplier information;
information from patient medical records; financial data; insurance reimbursement methodologies, strategies and practices; product and
service pricing methodologies, strategies and practices; contracts with physicians, providers, provider networks, payors, physician databases
and contracts with hospitals; regulatory and clinical manuals; and business plans, prospects and opportunities (such as possible acquisitions
or dispositions of businesses or facilities) that have been discussed or considered by the Employer or its Affiliates, including, without
limitation, the management of the Employer or its Affiliates. Confidential Information includes information developed by the Employee
in the course of the Employee&rsquo;s employment by the Employer, as well as other information to which the Employee may have access in
connection with the Employee&rsquo;s employment. Confidential Information also includes the confidential information of others with which
the Employer or its Affiliates has a business relationship. Notwithstanding the foregoing, Confidential Information does not include information
in the public domain, unless due to breach of the Employee&rsquo;s duties under <U>Section 6(b)</U>, unless otherwise due to Employee&rsquo;s
breach of the obligations in this Agreement, or unless due to violation of another Person&rsquo;s obligations to the Employer or its Affiliates
that Employee should have taken reasonable measures to prevent but that Employee did not take.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Confidentiality</U>. The Employee understands and agrees that the Employee&rsquo;s employment creates a relationship of confidence
and trust between the Employer and the Employee with respect to all Confidential Information. At all times, both during the Employee&rsquo;s
employment with the Employer and after the Employee&rsquo;s termination from employment for any reason, the Employee shall keep in confidence
and trust all such Confidential Information, and shall not use, disclose, or transfer any such Confidential Information without the written
consent of the Employer, except as may be necessary within the scope of Employee&rsquo;s duties with Employer and in the ordinary course
of performing the Employee&rsquo;s duties to the Employer or as otherwise provided in <U>Section 6(c)</U>. Employee understands and agrees
not to sell, license or otherwise exploit any products or services which embody or otherwise exploit in whole or in part any Confidential
Information or materials. Employee acknowledges and agrees that the sale, misappropriation, or unauthorized use or disclosure in writing,
orally or by electronic means, at any time of Confidential Information obtained by Employee during or in connection with the course of
Employee&rsquo;s employment constitutes unfair competition. Employee agrees and promises not to engage in unfair competition with Employer
or its Affiliates, either during employment, or at any time thereafter. Employee further agrees (unless required by the Employer in connection
with employment or with the Employer's express written consent) not to copy, take, or remove any of the Employer's books, records, customer
lists, or any other documents or materials from the Employer's premises, including Human Resources manuals, materials, and forms. The
Employee shall not, at any time whatsoever, either during the Term of this Agreement or after its termination, disclose to others, either
directly or indirectly, or take or use for the Employee&rsquo;s own competitive purposes or the competitive purposes of others, either
directly or indirectly, any confidential information, knowledge or data of the Employer. Upon (a) the voluntary or involuntary termination
of employment with the Employer for whatever reason; or (b) at any time the Employer demands, Employee shall promptly deliver to the Employer
at his or her sole cost any and all of the Employer's books, records, confidential information, and/or any other documents or materials
which are in Employee&rsquo;s possession or under Employee&rsquo;s control or any copies thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Protected Rights</U>. Notwithstanding anything to the contrary in this <U>Section 6</U>, this Agreement is not intended to,
and shall not, in any way prohibit, limit or otherwise interfere with the Employee&rsquo;s protected rights under federal, state or local
law to, without notice to the Employer, (i) communicate or file a charge with a government regulator; (ii) participate in an investigation
or proceeding conducted by a government regulator; or (iii) receive an award paid by a government regulator for providing information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Documents, Records, etc</U>. All documents, records, data, apparatus, equipment and other physical property, whether or not
pertaining to Confidential Information, that are furnished to the Employee by the Employer or its Affiliates or are produced by the Employee
in connection with the Employee&rsquo;s employment will be and remain the sole property of the Employer and its Affiliates. The Employee
shall return to the Employer all such materials and property as and when requested by the Employer. I n any event, the Employee shall
return all such materials and property immediately upon termination of the Employee&rsquo;s employment for any reason. The Employee shall
not retain any such material or property or any copies thereof after such termination. It is specifically agreed that any documents, card
files, notebooks, programs, or similar items containing customer or patient information are the property of the Employer and its Affiliates
regardless of by whom they were compiled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Notice to Employee</U>. Employee acknowledges that the Employer has informed Employee that in accordance with 18 U.S.C. &sect;
1833(b), that Employee may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of
a trade secret where the disclosure either is made (1) in confidence to a federal, state, or local government official, either directly
or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or is made
in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Disclosure Prevention</U>. The Employee will take all reasonable precautions to prevent the inadvertent or accidental exposure
of Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Removal of Material</U>. The Employee will not remove any Confidential Information from the Employer&rsquo;s or its Affiliate&rsquo;s
premises except for use in the Employer&rsquo;s business, and only consistent with the Employee&rsquo;s duties with the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Copying</U>. The Employee agrees that copying or transferring Confidential Information (by any means) shall be done only as
needed in furtherance of and for use in the Employer&rsquo;s and its Affiliate&rsquo;s business, and consistent with the Employee&rsquo;s
duties with the Employer. The Employee further agrees that copies of Confidential Information shall be treated with the same degree of
confidentiality as the original information and shall be subject to all restrictions herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Computer
Security</U>. The Employee agrees to comply with the Employer&rsquo;s policies and procedures concerning computer security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>E-Mail</U>.
The Employee acknowledges that the Employer retains the right to review any and all electronic mail communications made with employer
provided email accounts, hardware, software, or networks, with or without notice, at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment</U>.
The Employee acknowledges that any and all inventions, discoveries, designs, developments, methods, modifications, trade secrets, processes,
software, formulae, data, &ldquo;know-how,&rdquo; databases, algorithms, techniques and works of authorship whether or not patentable
or protectable by copyright or trade secret, made or conceived, first reduced to practice, or learned by the Employee, either alone or
jointly with others, during the Term that (i) relate to or are useful in the business of the Employer or its Affiliates, or (ii) are conceived,
made or worked on at the expense of or during the Employee&rsquo;s work time for the Employer, or using any resources or materials of
the Employer or its Affiliates, or (iii) arise out of tasks assigned to the Employee by the Employer (together &ldquo;<U>Proprietary Inventions</U>&rdquo;)
will be the sole property of the Employer or its Affiliates. The Employee acknowledges that all work performed by the Employee is on a
 &ldquo;work for hire&rdquo; basis and the Employee hereby assigns or agrees to assign to the Employer the Employee&rsquo;s entire right,
title and interest in and to any and all Proprietary Inventions and related intellectual property rights. The Employee agrees to assist
the Employer to obtain, maintain and enforce intellectual property rights for Proprietary Inventions in any and all countries during the
Term, and thereafter for as long as such intellectual property rights exist.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>NOTICE TO CALIFORNIA EMPLOYEES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to California Labor Code &sect;2870,
an agreement requiring the employee to assign or offer to assign any of his or her rights in any invention to his or her employer does
not apply to an invention which qualifies fully under the provisions of California Labor Code &sect; 2870, which provides as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;(a) Any provision
in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention
to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer&rsquo;s
equipment, supplies, facilities, or trade secret information except for those inventions that either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-size: 10pt">&ldquo;(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Relate at the time of conception or reduction to practice of the invention to the employer&rsquo;s business, or actual or demonstrably
anticipated research or development of the employer; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.45in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-size: 10pt">&ldquo;(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Result from any work performed by the employee for the employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.45in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;(b) To the extent
a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to
be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restricted
Activities</U>. Employee agrees and covenants that, at any time during Employee&rsquo;s employment with the Employer and for a period
of twelve (12) months immediately following the termination of Employee&rsquo;s relationship with the Employer for any reason, whether
with or without cause, Employee shall not, either on Employee&rsquo;s own behalf or on behalf of any other Person, take any action or
engage in any unfair business practice, including, without limitation, any misappropriation of confidential, proprietary or trade secret
information of the Employer or its Affiliates, as a result of which relations between the Employer or its Affiliates, and any of their
customers, clients, suppliers, distributors or others, may be impaired or which might otherwise be detrimental to the business interests
or reputation of the Employer or its Affiliates. Employee acknowledges that there is a substantial likelihood that the activities described
in this Section would (a) involve the unauthorized use or disclosure of Employer&rsquo;s or an Affiliate&rsquo;s Confidential Information
and that use or disclosure would be extremely difficult to detect, and (b) result in substantial competitive harm to the business of Employer
or an Affiliate. Employee has accepted the limitations of this Section as a reasonably practicable and unrestrictive means of preventing
such use or disclosure of Confidential Information and preventing such competitive harm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Third-Party Agreements and Rights</U>. The Employee hereby confirms that the Employee is not bound by the terms of any agreement
with any previous employer or other party which restricts in any way the Employee&rsquo;s use or disclosure of information or the Employee&rsquo;s
engagement in any business except as Employee has previously provided written notice to Employer and has attached to this Agreement. The
Employee represents to the Employer that the Employee&rsquo;s execution of this Agreement, the Employee&rsquo;s employment with the Employer
and the performance of the Employee&rsquo;s proposed duties for the Employer will not violate any obligations the Employee may have to
any previous employer or other party. In the Employee&rsquo;s work for the Employer, the Employee will not disclose or use any information
in violation of any agreements with or rights of any such previous employer or other party, and the Employee will not bring to (by any
means) the premises of the Employer any copies or other tangible embodiments of non-public information belonging to or obtained from any
such previous employment or other party. <U>Litigation and Regulatory Cooperation</U>. During and after the Employee&rsquo;s employment,
the Employee shall cooperate fully with the Employer in the defense or prosecution of any claims or actions now in existence or that may
be brought in the future against or on behalf of the Employer that relate to events or occurrences that transpired while the Employee
was employed by the Employer. The Employee&rsquo;s full cooperation in connection with such claims or actions shall include, but not be
limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Employer at
mutually convenient times. During and after the Employee&rsquo;s employment, the Employee also shall cooperate fully with the Employer
in connection with any investigation or review of any federal, state, or local regulatory authority as any such investigation or review
relates to events or occurrences that transpired while the Employee was employed by the Employer. The Employer shall reimburse the Employee
for any reasonable out of pocket expenses, including, but not limited to, actual missed wages, incurred in connection with the Employee&rsquo;s
performance of obligations pursuant to this <U>Section</U>. &ldquo;Full cooperation&rdquo; shall not be construed to in any way require
any violation of law or any testimony that is false or misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Enforcement; Injunction</U>. The Employee acknowledges and agrees that the restrictions contained in this Agreement are reasonable
and necessary to protect the business and interests of the Employer and its Affiliates, do not create any undue hardship for the Employee,
and that any violation of the restrictions in this Agreement would cause the Employer and its Affiliates substantial irreparable injury.
Accordingly, the Employee agrees that a remedy at law for any breach or threatened breach of the covenants or other obligations in <U>Section
6</U> of this Agreement would be inadequate and that the Employer, in addition to any other remedies available, shall be entitled to obtain
preliminary and permanent injunctive relief to secure specific performance of such covenants and to prevent a breach or contemplated or
threatened breach of this Agreement without the necessity of proving actual damage and without the necessity of posting bond or security,
which the Employee expressly waives. Moreover, the Employee will provide the Employer a full accounting of all proceeds and profits received
by the Employee as a result of or in connection with a breach of <U>Section 6</U> of this Agreement. Unless prohibited by law, the Employer
shall have the right to retain any amounts otherwise payable by the Employer to the Employee to satisfy any of the Employee&rsquo;s obligations
as a result of any breach of <U>Section 6</U> of this Agreement. The Employee hereby agrees to indemnify and hold harmless the Employer
and its Affiliates from and against any damages incurred by the Employer or its Affiliates as assessed by a court of competent jurisdiction
as a result of any breach of <U>Section 6</U> of this Agreement by the Employee. Likewise, the Employer hereby agrees to indemnify and
hold harmless the Employee from and against any damages incurred by the Employee as assessed by a court of competent jurisdiction as a
result of any breach of <U>Section 6</U> of this Agreement by the Employer. The prevailing party shall be entitled to recover its reasonable
attorneys&rsquo; fees and costs if it prevails in any action to enforce <U>Section 6</U> of this Agreement. It is the express intention
of the parties that the obligations of <U>Section 6</U> of this Agreement shall survive the termination of the Employee&rsquo;s employment.
The Employee agrees that each obligation specified in <U>Section 6</U> of this Agreement is a separate and independent covenant that shall
survive any termination of this Agreement and that the unenforceability of any of them shall not preclude the enforcement of any other
covenants in <U>Section 6</U> of this Agreement. No change in the Employee&rsquo;s duties or compensation shall be construed to affect,
alter or otherwise release the Employee from the covenants herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Successors</U>. This Agreement shall be binding upon and inure to the benefit of both parties and their respective successors
and permitted assigns, except it shall not be binding to Employee where any corporation or entity with which or into which the Employer
may be merged or which may succeed to its assets or business wherein there has been a Change of Control. Where succession is permissible,
Employee&rsquo;s obligations are personal and shall not be assigned by Employee. The Employee consents to be bound by the provisions of
this Agreement, except in circumstances of a Change of Control, for the benefit of the Employer or its Affiliates to whose employ the
Employee may be transferred without the necessity that this Agreement be resigned at the time of such transfer. In the event of the Employee&rsquo;s
death after the Date of Termination but prior to the completion by the Employer of all payments due to the Employee under this Agreement,
the Employer shall continue such payments to the Employee&rsquo;s beneficiary designated in writing to the Employer prior to the Employee&rsquo;s
death (or to the Employee&rsquo;s estate, if the Employee fails to make such designation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Enforceability</U>.
If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction,
then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it
is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid
and enforceable to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Waiver</U>.
No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party
to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall
not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notices</U>. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in
writing and delivered in person or sent by registered or certified mail, postage prepaid, to the Employee at the last address for which
the Employee has provided written notice to the Employer, or to the Employer at its main office, to the attention of Human Resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Publicity</U>.
The Employee hereby grants to the Employer the right to use the Employee&rsquo;s name and likeness, without additional consideration,
on, in and in connection with technical, marketing, regulatory filings and/or disclosure materials published by or for the Employer for
the duration of Employee&rsquo;s employment with Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Conflicting
Obligations and Rights</U>. The Employee agrees to inform the Employer in writing of any apparent conflicts between the Employee&rsquo;s
work for the Employer and (a) any obligations the Employee may have to preserve the confidentiality of another&rsquo;s proprietary information
or materials or (b) any rights the Employee claims to any inventions or ideas before using the same on the Employer&rsquo;s behalf. Otherwise,
the Employer may conclude that no such conflict exists and the Employee agrees thereafter to make no such claim against the Employer.
The Employer shall receive such disclosures in confidence and consistent with the objectives of avoiding any conflict of obligations
and rights or the appearance of any conflict of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">13.&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notification of New Employer</U>. In the event that the Employee leaves the employ of the Employer, voluntarily or involuntarily,
the Employee agrees to inform any subsequent employer of the Employee&rsquo;s obligations under <U>Section 6</U> of this Agreement. The
Employee further hereby authorizes the Employer to notify the Employee&rsquo;s new employer about the Employee&rsquo;s obligations under
<U>Section 6</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">14.&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Entire
Agreement</U>. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes
any previous oral or written communications, negotiations, representations, understandings, or agreements between them. Any modification
of this Agreement shall be effective only if set forth in a written document signed by the Employee and a duly authorized officer of
the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Agreement may be amended or modified only by a written instrument signed by the Employee and by a duly authorized representative
of the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be construed under and be governed in all respects by the laws of the State of Delaware, without giving
effect to the conflict of laws principles of such State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Obligations
of Successors</U>. The Employer shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Employer to expressly assume and agree to perform this Agreement in the
same manner and to the same extent that the Employer would be required to perform if no such succession had taken place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
Recovery Policy</U>. The Employee expressly acknowledges and agrees that, notwithstanding any provision of this Agreement to the contrary,
any compensation granted to, earned by, payable to or received by the Employee shall be subject to forfeiture or repayment to the Employer
and its Affiliates, to the extent required by the Astrana Health, Inc. Compensation Recovery Policy, as the same may be amended from
time to time (or any successor policy thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
on Payments in Certain Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Limitation on Payments</U>. Notwithstanding anything to the contrary in <U>Section</U> 3 and <U>Section 5</U> of this Agreement,
if any payment or distribution that the Employee would receive pursuant to this Agreement or otherwise (&ldquo;<U>Payment</U>&rdquo;)
would (a) constitute a &ldquo;parachute payment&rdquo; within the meaning of Section 280G of the Code), and (b) but for this sentence,
be subject to the excise tax imposed by Section 4999 of the Code (the &ldquo;<U>Excise Tax</U>&rdquo;), then the Employer shall cause
to be determined, before any amounts of the Payment are paid to the Employee, which of the following alternative forms of payment would
maximize the Employee&rsquo;s after-tax proceeds: (i) payment in full of the entire amount of the Payment (a &ldquo;<U>Full Payment</U>&rdquo;),
or (ii) payment of only a part of the Payment so that the Employee receives that largest Payment possible without being subject to the
Excise Tax (a &ldquo;<U>Reduced Payment</U>&rdquo;), whichever of the foregoing amounts, taking into account the applicable federal, state
and local income taxes and the Excise Tax (all computed at the highest marginal rate, net of the maximum reduction in federal income taxes
which could be obtained from a deduction of such state and local taxes), results in the Employee&rsquo;s receipt, on an after-tax basis,
of the greater amount of the Payment, notwithstanding that all or some portion the Payment may be subject to the Excise Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The independent registered public accounting firm engaged by the Employer for general audit purposes as of the day prior to the
date the first Payment is due shall make all determinations required to be made under this <U>Section 18</U>. If the independent registered
public accounting firm so engaged by the Employer is serving as accountant or auditor for the individual, group or entity effecting the
transaction, the Employer shall appoint a nationally recognized independent registered public accounting firm to make the determinations
required hereunder. The Employer shall bear all expenses with respect to the determinations by such independent registered public accounting
firm required to be made hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The independent registered public accounting firm engaged to make the determinations hereunder shall provide its calculations,
together with detailed supporting documentation, to the Employer and the Employee at such time as requested by the Employer or the Employee.
If the independent registered public accounting firm determines that no Excise Tax is payable with respect to a Payment, either before
or after the application of the Reduced Payment, it shall furnish the Employer and the Employee with an opinion reasonably acceptable
to the Employee that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm
made hereunder shall be final, binding and conclusive upon the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consent
to Jurisdiction; Forum Selection</U>. At all times the Employee and Employer: (a) irrevocably submit to the exclusive jurisdiction of
the state and federal courts for the county in which the Employer&rsquo;s headquarters are located, whichever may have competent subject
matter jurisdiction, in any action or proceeding arising out of or relating to this Agreement, and irrevocably agree that all claims
in respect of any such action or proceeding may be heard and determined in such court; (b) to the extent permitted by law, irrevocably
consent to the service of any and all process in any such action or proceeding by the mailing of copies of such process to such party
at the address set forth in this Agreement (or otherwise on record with the Employer); (c) to the extent permitted by law, irrevocably
confirm that service of process out of such courts in such manner shall be deemed due service upon such party for the purposes of such
action or proceeding; (d) to the extent permitted by law, irrevocably waives (i) any objection the Employee or Employer may have to the
laying of venue of any such action or proceeding in any of such courts, or (ii) any claim that the Employee or Employer may have that
any such action or proceeding has been brought in an inconvenient forum; and (e) to the extent permitted by law, irrevocably agrees that
a final nonappealable judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit
on the judgment or in any other manner provided by law. Nothing in this <U>Section</U> shall affect the right of any party hereto to
serve legal process in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts</U>.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original;
but such counterparts shall together constitute one and the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, this Agreement,
as amended and restated as set forth herein, has been executed as a sealed instrument by the Employer by its duly authorized officer,
and by the Employee, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EMPLOYER</U>:</B></FONT></TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EMPLOYEE</U>:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASTRANA HEALTH MANAGEMENT, INC.</FONT></TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brandon Sim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Chandan Basho</FONT></TD>
    <TD STYLE="width: 2%">&#8239;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brandon Sim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chandan Basho</FONT></TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&#8239;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer and Financial Officer</FONT></TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD COLSPAN="2">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4, 2024</FONT></TD>
    <TD>&#8239;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4, 2024</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2410938d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amended and Restated as of April 2, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>EMPLOYMENT AGREEMENT
</B>(this &ldquo;<U>Agreement</U>&rdquo;) by and between Astrana Health, Inc., a Delaware corporation (the &ldquo;<U>Employer</U>&rdquo;),
and Chandan Basho (the &ldquo;<U>Employee</U>,&rdquo; and together with the Employer, collectively referred to as the &ldquo;<U>Parties</U>&rdquo;),
amends and restates and supersedes in its entirety, effective as of April 2, 2024 (the &ldquo;<U>Restatement Date</U>&rdquo;), that certain
Employment Agreement by and between Astrana Health Management, Inc. (formerly known as Network Medical Management, Inc.) and the Employee
that originally became effective on April 12, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Employer desires
to continue to employ the Employee on the terms and conditions set forth below, and the Employee is willing to serve the Employer on such
terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Engagement and Duties</U>. Employer shall continue to employ the Employee as Chief Operating Officer and Chief Financial
Officer during the Term of this Agreement, to perform the duties customarily associated with such offices and such other duties as may
be assigned to the Employee from time to time by Employer&rsquo;s Chief Executive Officer and President. Employee hereby accepts such
employment by Employer upon the terms and subject to conditions set forth in this Agreement. Employee shall report to Brandon Sim, Chief
Executive Officer and President. Employee shall devote his best efforts, skills and abilities, on a full-time basis, exclusively to the
Employer&rsquo;s business. Employee covenants and agrees to faithfully adhere to and fulfill such policies as are established from time
to time by the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) of Astrana Health, Inc. (formerly known as Apollo Medical Holdings,
Inc.) (&ldquo;<U>Astrana Health</U>&rdquo;) or the Employer (&ldquo;<U>Policies</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Performance of Services for Affiliates</U>. In addition to the performance of services for Employer, Employee shall,
to the extent so required by Employer, also perform services for its &ldquo;Affiliates&rdquo; (as defined in <U>Section 6</U> below),
provided that such services are consistent with the kind of services Employee performs or may be required to perform for Employer under
this Agreement. If Employee performs any services for any Affiliate, Employee shall not be entitled to receive any compensation or remuneration
in addition to or in lieu of the compensation and remuneration provided under this Agreement on account of such services for the Affiliate.
The Policies will govern Employee&rsquo;s employment by Employer and its Affiliates for which Employee is asked to provide services. In
addition, Employee covenants and agrees that Employee will faithfully adhere to and fulfill such additional policies as may be established
from time to time by the board of directors of any Affiliate for which Employee performs services, to the extent that such policies and
procedures differ from or are in addition to the Policies adopted by Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Conflicting Obligations</U>. Employee represents and warrants to Employer that Employee is under no obligations or
commitments, whether contractual or otherwise, that are inconsistent with Employee&rsquo;s obligations under this Agreement or that would
prohibit Employee, contractually or otherwise, from performing Employee&rsquo;s duties under this Agreement and the Policies; provided,
however, that Employee may participate as a member of the board of directors or advisory board of other entities and in professional organizations
and civic and charitable organizations, so long as any such positions are disclosed to the Board and do not materially interfere with
the Employee&rsquo;s responsibilities and duties to the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Unauthorized Use of Third-Party Intellectual Property</U>. Employee represents and warrants to Employer that Employee
will not use or disclose, in connection with Employee&rsquo;s employment by Employer or any Affiliate, any patents, trade secrets, confidential
information, or other proprietary information or intellectual property as to which any other person has any right, title or interest,
except to the extent that Employer or its Affiliate holds a valid license or other written permission for such use from the owner(s) thereof.
Employee represents and warrants to Employer that Employee has returned all property and confidential information belonging to any prior
employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Term</U>.
The initial term of this Agreement, as amended and restated, shall be for a three (3) year period commencing on the Restatement Date.
The term of this Agreement shall automatically renew for an additional year on each applicable anniversary of the Restatement Date unless
either Party gives the other written notice of intent not to renew at least sixty (60) days prior to such date. Notwithstanding the foregoing,
the initial term and any renewal year shall be subject to earlier termination as provided in&#8239;<U>Section 4</U>&#8239;below. The initial
term and any renewal years are referred to herein as the &ldquo;<U>Term</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
and Related Matters</U>. The Employer shall provide the Employee with the compensation and benefits set forth in this <U>Section 3</U>
during the Term. Authority to take action under this Section 3 with respect to the Employee&rsquo;s compensation and benefits may be delegated
by the Board to its compensation committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Base Salary</U>. The Employer shall pay the Employee, as an exempt employee, for all services rendered a base salary
of $600,000 per year (the &ldquo;<U>Base Salary</U>&rdquo;), payable, bi-weekly, and in accordance with the Employer&rsquo;s payroll procedures,
subject to customary withholdings and employment taxes. The Base Salary shall be evaluated at least annually by the Board for increase
only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Annual Bonus</U>. In the Employer&rsquo;s sole discretion, the Employee is eligible to receive an annual cash bonus (the
 &ldquo;<U>Annual Bonus</U>&rdquo;) with a target Annual Bonus opportunity of 80% of the Employee&rsquo;s Base Salary for each fiscal year
during the Term on such terms and conditions as the Board shall determine in its discretion consistent with the terms of the Employer&rsquo;s
business plan. The target Annual Bonus opportunity (as a percentage of Base Salary) shall be evaluated at least annually by the Board
for increase only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Long Term Incentive Awards</U>. In the Employer&rsquo;s sole discretion, the Employee may be eligible to participate
in any long term incentive plan that may be available to similarly positioned executives. The Board may determine to grant long-term incentive
awards in cash or in equity awards settled in shares of the Employer&rsquo;s or its Affiliates&rsquo; stock, including but not limited
to stock options, restricted stock and performance shares. Any equity or options will be granted according to the latest Equity Incentive
Plan approved by the Board and the stockholders of Astrana Health. A &ldquo;<U>No Fault Separation</U>&rdquo; means that, during the Term,
either the Employee has resigned for Good Reason (as defined in <U>Section 4(e)</U> below), the Employer has terminated the Employee&rsquo;s
employment without Cause (as defined in <U>Section 4(d)</U> below or the Employee terminates employment on account of death or Disability
(as defined in <U>Sections 4(a) &amp; (b)</U> below). In the event the Employee terminates service due to a No Fault Separation, any requirements
under any long-term incentive award held by the Employee shall be deemed to have been satisfied by the Employer immediately prior to such
termination. For avoidance of doubt, a No Fault Separation entitles the Employee to be 100% vested with respect to any stock options with
vesting conditions based solely on continued employment, and to be entitled to payment with respect to any long-term incentive award subject
to corporate or business goals to the extent that such goals are met during the performance period on the same basis as if he had remained
continuously employed with the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Paid Time Off</U>. During the Term, the Employee will be eligible for paid time off in accordance with
and subject to all of the terms and conditions of the Employer&rsquo;s Paid Time Off policy (which such policy is compliant with CA&rsquo;s
Paid Sick Leave requirements, to the extent applicable), as such policy may be amended from time to time in the Employer&rsquo;s sole
discretion. Employee will also be eligible for paid holidays, in accordance with and subject to all of the terms and conditions of the
Employer&rsquo;s policies, as such policies may be amended from time to time or terminated in the Employer&rsquo;s sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Expenses</U>. The Employee shall be entitled to prompt reimbursement of reasonable and usual business expenses incurred
on behalf of Employer in accordance with the Employer&rsquo;s expense reimbursement policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Benefits</U>. The Employee shall be entitled to continue to participate in or receive benefits under any employee benefit
plan or arrangement which is or may, in the future, be made available by the Employer to its employees, subject to and on a basis consistent
with the terms, conditions and overall administration of such plan or arrangement. Irrespective of other benefits provided to employees,
the Employee&rsquo;s benefits package shall include: (i) the Employer&rsquo;s payment of premiums for medical, dental and vision care
coverage; (ii) the Employer&rsquo;s payment of insurance premiums for short-term and long-term disability insurance providing for no less
than sixty percent (60%) of Employee&rsquo;s Base Salary to be payable to the Employee as long as the covered disability persists in a
manner that substantially prevents employment in the same occupation as the position Employee last held with Employer but not beyond age
sixty-five (65); and (iii) the Employer&rsquo;s payment of insurance premiums for term life insurance providing for no less than two million
dollars of coverage (subject to meeting applicable underwriting requirements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Tax Withholding.</U> The Employer shall undertake to make deductions, withholdings and tax reports with respect to payments
and benefits under this Agreement, to the extent it reasonably and in good faith believes it is required to make such deductions, withholdings
and tax reports. Payments with respect to compensation and benefits referred to under this Agreement shall be in amounts net of any such
deductions or withholdings. Nothing in this Agreement shall be construed to require the Employer to make any payments to compensate the
Employee for any adverse tax effect associated with any payments or benefits, or for any deduction or withholding from any payment or
benefit. Employee will be solely responsible for and will satisfy all of Employee&rsquo;s tax obligations associated with all compensation
paid or provided to Employee under this Employment Agreement. Employee acknowledges and agrees that Employee is not relying on any advice
from the Employer or any Employer affiliate, officer, director, employee, agent or attorney with respect to any tax issue relating to
this Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Directors And Officers Insurance</U>. Employee will be covered as a named insured within the Directors and Officers insurance
policy of the Employer and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
The Employee&rsquo;s employment hereunder may be terminated during the Term without any breach of this Agreement under the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Death</U>. The Employee&rsquo;s employment hereunder shall terminate upon the Employee&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Disability</U>. The Employer may terminate the Employee&rsquo;s employment if the Employee is disabled for 90 or more
consecutive days and, because of the disability, is unable to perform the essential functions of the Employee&rsquo;s then existing position
or positions under this Agreement with or without reasonable accommodation. This provision is not intended to reduce any rights the Employee
may have pursuant to any law, including without limitation (and to the extent applicable) the California Family Rights Act, the Family
and Medical Leave Act, the California Fair Employment and Housing Act, and the Americans with Disabilities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Termination by the Employer for Cause</U>. At any time during the Term, the Employer may terminate the Employee&rsquo;s
employment hereunder for Cause. For purposes of this Agreement, &ldquo;<U>Cause</U>&rdquo; shall mean: (i) conduct by the Employee constituting
a material act of willful misconduct in connection with the performance of the Employee&rsquo;s duties that results in loss, damage or
injury that is material to the Employer; (ii) the Employee&rsquo;s conviction of, or plea of guilty or nolo contendere to, any felony;
(iii) continued, willful and deliberate non-performance by the Employee of the Employee&rsquo;s duties hereunder (other than by reason
of the Employee&rsquo;s physical or mental illness, incapacity or disability); (iv) a material breach by the Employee of&#8239;<U>Section
6</U>&#8239;of this Agreement that results in loss, damage or injury that is material to the Employer; (v) willful failure to cooperate
with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the
Employer to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation
or the willful inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigations;
or (vi) fraud, embezzlement or theft against the Employer or any of its Affiliates (as defined in&#8239;<U>Section 6(a)</U>&#8239;below).
With respect to the events in (i), (iii) and (iv) herein, the Employer shall have delivered written notice to the Employee of its intention
to terminate the Employee&rsquo;s employment for Cause, which notice specifies in reasonable detail the circumstances claimed to give
rise to the Employer&rsquo;s right to terminate the Employee&rsquo;s employment for Cause and the Employee shall not have cured such circumstances
to the extent such circumstances are reasonably susceptible to cure as determined by the Board in good faith within sixty (60) days following
the Employer&rsquo;s delivery of such notice. For avoidance of doubt, &ldquo;Cause&rdquo; shall not include (x) expense reimbursement
disputes in which the Employee acts in reasonable good faith; (y) occasional, customary and de minimis use of the Employer&rsquo;s property
for personal purposes; and (z) acting in good faith upon advice of Employer&rsquo;s legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Termination by Employer without Cause</U>. At any time during the Term, the Employer may terminate the Employee&rsquo;s
employment hereunder without Cause by providing the Employee with sixty (60) days advance written notice. Any termination by the Employer
of the Employee&rsquo;s employment under this Agreement that does not constitute a termination for Cause under <U>Section 4(c)</U> and
does not result from the death or Disability of the Employee under <U>Sections 4(a)</U> or <U>4(b)</U> shall be deemed a termination without
Cause under this <U>Section 4(d)</U>. Any suspension of the Employee&rsquo;s employment with pay or benefits by the Board in good faith
pending an investigation of alleged improper activities by the Employee that, if determined to be accurate, would be grounds for a Cause
termination, shall not be considered a termination of the Employee&rsquo;s employment without Cause or provide with Good Reason to terminate
employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Termination by the Employee</U>. At any time during the Term, the Employee may terminate his employment hereunder for
any reason, including, but not limited to, Good Reason. For purposes of this Agreement, &ldquo;<U>Good Reason</U>&rdquo; shall mean that
the Employee has complied with the &ldquo;<U>Good Reason Process</U>&rdquo; (hereinafter defined) following the occurrence of any of the
following events without the Employee&rsquo;s written consent: (i) a reduction in the Employee&rsquo;s Base Salary; (ii) a diminution
in the Employee&rsquo;s responsibilities, authority or duties (including, without limitation, a requirement that the Employee report to
any person other than Brandon Sim, Chief Executive Officer and President); or (iii) the material breach of this Agreement by the Employer,
including but not limited to a failure to pay Base Salary or Annual Bonus when due under this Agreement; or (iv) Brandon Sim is no longer
part of the management team of Astrana Health or one of its wholly owned subsidiaries. &ldquo;<U>Good Reason Process</U>&rdquo; shall
mean (A) the Employee reasonably determines in good faith that a &ldquo;Good Reason&rdquo; condition has occurred; (B) the Employee notifies
the Employer in writing of the occurrence of the Good Reason condition within (60) days of the occurrence of such condition; (C) the Employee
cooperates in good faith with the Employer&rsquo;s efforts, for a period of sixty (60) days following such notice (the &ldquo;<U>Cure
Period</U>&rdquo;), to remedy the condition; (D) notwithstanding such efforts, the Good Reason condition continues to exist; and (E) the
Employee terminates his employment within fourteen (14) days after the end of the Cure Period. If the Employer cures the Good Reason condition
during the Cure Period, Good Reason shall be deemed not to have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Change of Control</U>. For purposes of this Agreement, &ldquo;Change of Control&rdquo; means the occurrence of any of
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
person (within the meaning Section 3(a)(9) of the Securities Exchange Act of 1934, as amended, and as used in Sections 13(d) and 14(d)
thereof, including a &ldquo;group&rdquo; as defined in Section 13(d) thereof) becomes the beneficial owner (within the meaning of Rule&#8239;13d-3
under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of Astrana Health representing more than
30% of the total voting power or value represented by Astrana Health&rsquo;s then outstanding voting securities (excluding for this purpose
any such voting securities held by Astrana Health or its subsidiaries or by any employee benefit plan of the Astrana Health or a subsidiary)
pursuant to a transaction or a series of related transactions; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
closing of either (A) A merger or consolidation of Astrana Health whether or not approved by the Board, other than a merger or consolidation
which would result in the voting securities of Astrana Health outstanding immediately prior thereto continuing to represent (either by
remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such corporation) more than
50% of the total voting power or value represented by the voting securities of Astrana Health or such surviving entity or parent of such
corporation, as the case may be, outstanding immediately after such merger or consolidation; or (B) the sale or disposition by Astrana
Health of all or substantially all of Astrana Health&rsquo;s assets; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
change in the composition of the Board, as a result of which fewer than a majority of the members of the Board are Incumbent Directors.
For this purpose, &ldquo;<U>Incumbent Directors</U>&rdquo; shall mean members of the Board who either (A)&#8239;are directors of Astrana
Health on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control, or (B)&#8239;are elected,
or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such
election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened
proxy contest relating to the election of directors of Astrana Health).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Notice of Termination</U>. Except for termination as specified in <U>Section 4(a)</U>, any termination of the Employee&rsquo;s
employment shall be communicated by written Notice of Termination by the terminating Party to the other Party hereto. For purposes of
this Agreement, a &ldquo;<U>Notice of Termination</U>&rdquo; shall mean a notice which shall indicate the specific termination provision
in this Agreement relied upon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Date of Termination</U>. &ldquo;<U>Date of Termination</U>&rdquo; shall mean the earliest of the following: (i) if the
Employee&rsquo;s employment is terminated by the Employee&rsquo;s death, the date of the Employee&rsquo;s death; (ii) if the Employee&rsquo;s
employment is terminated on account of Disability under <U>Section 4(b)</U> or by the Employer for Cause under <U>Section 4(c)</U>, the
date on which Notice of Termination is given that follows any applicable required cure period; (iii) if the Employee&rsquo;s employment
is terminated by the Employer under <U>Section 4(d)</U>, sixty (60) days after the date on which a Notice of Termination is given; (iv)
if the Employee&rsquo;s employment is terminated by the Employee under <U>Section 4(e)</U> without Good Reason, sixty (60) days after
the date of which a Notice of Termination is given or such shorter period agreed to by the Employer; or (v) if the Employee&rsquo;s employment
is terminated by the Employee under <U>Section 4(e)</U> with Good Reason, the date on which Notice of Termination is given after the end
of the Cure Period. Notwithstanding the foregoing, in the event that the Employee gives a Notice of Termination to the Employer, the Employer
may unilaterally accelerate the Date of Termination but such acceleration shall nevertheless be deemed a termination without Cause by
the Employer, on the accelerated date for purposes of this Agreement. For purposes of determining the time when the Severance Amount,
is to be paid under <U>Section 5(b)(i)</U> of this Agreement, &ldquo;<U>Date of Termination</U>&rdquo; means the Employee&rsquo;s separation
from service as defined under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
upon Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Accrued Benefits</U>. If the Employee&rsquo;s employment with the Employer is terminated for any reason during the Term,
the Employer shall pay or provide the Employee (or the Employee&rsquo;s authorized representative or estate) any earned but unpaid Base
Salary or Annual Bonus for services rendered through the Date of Termination, unpaid expense reimbursements, and accrued but unused paid
time off (the &ldquo;<U>Accrued Benefits</U>&rdquo;) within the time prescribed by applicable law. With respect to vested compensation
or benefits the Employee may have under any employee benefit or compensation plan, program or arrangement of the Employer, payment will
be made to the Employee under the terms of the applicable plan, program or arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Termination by the Employer without Cause or by the Employee with Good Reason</U>. If the Employee&rsquo;s employment
is terminated by the Employer without Cause as provided in Section 4(d), or the Employee terminates his employment for Good Reason as
provided in Section 4(e), then (x) the Employer shall, through the Date of Termination, pay the Employee his or her Accrued Benefits,
and (y) if the Employee signs a general release of claims on a form provided by the Employer for such purpose (the &ldquo;<U>Release</U>&rdquo;)
within twenty-one (21) days of the receipt of the form of the Release (extended to forty-five (45) days in the event of a group termination
or exit incentive program) and does not revoke such Release during the seven-day revocation period:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>the Employer shall pay the Employee an amount equal to one (1) year of the Employee&rsquo;s most recent Base Salary, if
such termination occurs outside of the Change of Control Protection Period, or two (2) years of the Employee&rsquo;s most recent Base
Salary, if such termination occurs during the Change of Control Protection Period (but in any case determined prior to any action involving
Base Salary that would constitute Good Reason) (the &ldquo;<U>Severance Amount</U>&rdquo;), subject to such payroll deductions and withholdings
as are required by law. The Severance Amount shall be paid in substantially equal amounts on each payroll date over a one-year period,
if such termination occurs outside of the Change of Control Protection Period, or over a two-year period, if such termination occurs during
the Change of Control Protection Period, in either case commencing as soon as practicable after the Release becomes effective and irrevocable
in accordance with its terms; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>the Employer shall pay the Employee an amount in cash equal to the Employer&rsquo;s premium amounts paid for coverage of
Employee at the time of the Employee&rsquo;s termination of coverage under the Employer&rsquo;s group medical, dental and vision programs
for a period of twelve (12) months, if such termination occurs outside of the Change of Control Protection Period, or a period of twenty-four
(24) months, if such termination occurs during the Change of Control Protection Period, to be paid directly to the Employee at the same
times such payments would be paid on behalf of a current employee for such coverage; <U>provided</U>, <U>however</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>No payments shall be made under this paragraph (ii) unless and until the Employee timely elects continued coverage under
such plan(s) pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 as amended (&ldquo;<U>COBRA</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>This paragraph (ii) shall not be read or construed as placing any restrictions upon amounts paid under this paragraph (ii)
as to their use;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>Payments under this paragraph (ii) shall cease as of the earliest to occur of the following: (1) the Employee is no longer
eligible for and continuing to receive the COBRA coverage elected in subparagraph (A); (2) the time period set forth in the first sentence
of this paragraph (ii); (3) the date on which the Employee first becomes eligible to enroll in a group health plan in which eligibility
is based on employment with an employer; and (4) if the Employer in good faith determines that payments under this paragraph (ii) would
result in a discriminatory health plan pursuant to the Patient Protection and Affordable Care Act of 2010, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>For purposes of this Section 5(b), the &ldquo;Change of Control Protection Period&rdquo; means the period beginning on (and
including) the date of a Change of Control and ending on the second anniversary of such Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>Each individual <U>payment</U> of Severance Amount under <U>Section 5(b)(i)</U>, and each payment under <U>Section 5(b)(ii)</U>
of this Agreement, shall be deemed to be a separate &ldquo;payment&rdquo; for purposes and within the meaning of Treasury Regulation Section
1.409A-2(b)(2)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>For each individual payment of the Severance Amount under <U>Section 5(b)(i)</U>, and each payment under <U>Section 5(b)(ii)</U>,
of this Agreement, to the extent considered &ldquo;non-qualified deferred compensation&rdquo; (&ldquo;<U>NQDC</U>&rdquo;) under Section
409A, then the Employer shall make any such payment not earlier than the earlier of: (x) the first payroll date which is six (6) months
following the Employee&rsquo;s separation from service (as defined under Section 409A) with the Employer, or (y) the date of Employee&rsquo;s
death. The Employer may in its sole discretion accelerate or defer (but not beyond the time limit set forth below) any severance payments
which do not constitute NQDC in order to allow for the payment of taxes due, but not beyond the time limit specified for such payment
such that the payment would be treated as NQDC. Further, in the event that the period in which Employee is required to provide the Release
begins in one calendar year and ends in the next calendar year, then, solely to the extent necessary to comply with Section 409A, any
payment pursuant to <U>Section 5(b)(i)</U> or <U>Section 5(b)(ii)</U> shall be made during the later calendar year. For purposes of this
Section 5, (A) &ldquo;<U>Section 409A</U>&rdquo; means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Confidential
Information/Competitive Activities/Intellectual Property/ Cooperation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U>.
As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&ldquo;<U>Affiliate</U>&rdquo; means, as to any Person, (A) any other Person which directly, or indirectly through one or
more intermediaries, controls such Person or is consolidated with such Person in accordance with GAAP, (ii) any other Person which directly,
or indirectly through one or more intermediaries, is controlled by or is under common control with such Person, or (B) any other Person
of which such Person owns, directly or indirectly, fifty percent (50%) or more of the common stock or equivalent equity interests. As
used herein, the term &ldquo;control&rdquo; means possession, directly or indirectly, of the power to direct or cause the direction of
the management or policies of a Person, whether through the ownership of voting securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&ldquo;<U>Person</U>&rdquo; means an individual, a corporation, a partnership, a limited liability company, an association,
a trust or any other entity or organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>&ldquo;<U>Confidential Information</U>&rdquo; means information belonging to the Employer or its Affiliates which is of
value to the Employer or any of its Affiliates in the course of conducting its business (whether having existed, now existing, or to be
developed or created during Employee&rsquo;s employment by Employer) and the disclosure of which could result in a competitive or other
disadvantage to the Employer or its Affiliates. Confidential Information includes, without limitation, contract terms and rates; negotiating
and contracting strategies; financial information, reports, and forecasts; inventions, improvements and other intellectual property; product
plans or proposed product plans; trade secrets; designs, processes or formulae; software; employee, customer, patient, provider and supplier
information; information from patient medical records; financial data; insurance reimbursement methodologies, strategies and practices;
product and service pricing methodologies, strategies and practices; contracts with physicians, providers, provider networks, payors,
physician databases and contracts with hospitals; regulatory and clinical manuals; and business plans, prospects and opportunities (such
as possible acquisitions or dispositions of businesses or facilities) that have been discussed or considered by the Employer or its Affiliates,
including, without limitation, the management of the Employer or its Affiliates. Confidential Information includes information developed
by the Employee in the course of the Employee&rsquo;s employment by the Employer, as well as other information to which the Employee may
have access in connection with the Employee&rsquo;s employment. Confidential Information also includes the confidential information of
others with which the Employer or its Affiliates has a business relationship. Notwithstanding the foregoing, Confidential Information
does not include information in the public domain, unless due to breach of the Employee&rsquo;s duties under <U>Section 6(b)</U>, unless
otherwise due to Employee&rsquo;s breach of the obligations in this Agreement, or unless due to violation of another Person&rsquo;s obligations
to the Employer or its Affiliates that Employee should have taken reasonable measures to prevent but that Employee did not take.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Confidentiality</U>. The Employee understands and agrees that the Employee&rsquo;s employment creates a relationship
of confidence and trust between the Employer and the Employee with respect to all Confidential Information. At all times, both during
the Employee&rsquo;s employment with the Employer and after the Employee&rsquo;s termination from employment for any reason, the Employee
shall keep in confidence and trust all such Confidential Information, and shall not use, disclose, or transfer any such Confidential Information
without the written consent of the Employer, except as may be necessary within the scope of Employee&rsquo;s duties with Employer and
in the ordinary course of performing the Employee&rsquo;s duties to the Employer or as otherwise provided in <U>Section 6(c)</U>. Employee
understands and agrees not to sell, license or otherwise exploit any products or services which embody or otherwise exploit in whole or
in part any Confidential Information or materials. Employee acknowledges and agrees that the sale, misappropriation, or unauthorized use
or disclosure in writing, orally or by electronic means, at any time of Confidential Information obtained by Employee during or in connection
with the course of Employee&rsquo;s employment constitutes unfair competition. Employee agrees and promises not to engage in unfair competition
with Employer or its Affiliates, either during employment, or at any time thereafter. Employee further agrees (unless required by the
Employer in connection with employment or with the Employer's express written consent) not to copy, take, or remove any of the Employer's
books, records, customer lists, or any other documents or materials from the Employer's premises, including Human Resources manuals, materials,
and forms. The Employee shall not, at any time whatsoever, either during the Term of this Agreement or after its termination, disclose
to others, either directly or indirectly, or take or use for the Employee&rsquo;s own competitive purposes or the competitive purposes
of others, either directly or indirectly, any confidential information, knowledge or data of the Employer. Upon (a) the voluntary or involuntary
termination of employment with the Employer for whatever reason; or (b) at any time the Employer demands, Employee shall promptly deliver
to the Employer at his or her sole cost any and all of the Employer's books, records, confidential information, and/or any other documents
or materials which are in Employee&rsquo;s possession or under Employee&rsquo;s control or any copies thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Protected Rights</U>. Notwithstanding anything to the contrary in this <U>Section 6</U>, this Agreement is not intended
to, and shall not, in any way prohibit, limit or otherwise interfere with the Employee&rsquo;s protected rights under federal, state or
local law to, without notice to the Employer, (i) communicate or file a charge with a government regulator; (ii) participate in an investigation
or proceeding conducted by a government regulator; or (iii) receive an award paid by a government regulator for providing information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Documents, Records, etc</U>. All documents, records, data, apparatus, equipment and other physical property, whether
or not pertaining to Confidential Information, that are furnished to the Employee by the Employer or its Affiliates or are produced by
the Employee in connection with the Employee&rsquo;s employment will be and remain the sole property of the Employer and its Affiliates.
The Employee shall return to the Employer all such materials and property as and when requested by the Employer. I n any event, the Employee
shall return all such materials and property immediately upon termination of the Employee&rsquo;s employment for any reason. The Employee
shall not retain any such material or property or any copies thereof after such termination. It is specifically agreed that any documents,
card files, notebooks, programs, or similar items containing customer or patient information are the property of the Employer and its
Affiliates regardless of by whom they were compiled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Notice to Employee</U>. Employee acknowledges that the Employer has informed Employee that in accordance with 18 U.S.C.
 &sect; 1833(b), that Employee may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure
of a trade secret where the disclosure either is made (1) in confidence to a federal, state, or local government official, either directly
or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or is made
in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Disclosure Prevention</U>. The Employee will take all reasonable precautions to prevent the inadvertent or accidental
exposure of Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Removal of Material</U>. The Employee will not remove any Confidential Information from the Employer&rsquo;s or its Affiliate&rsquo;s
premises except for use in the Employer&rsquo;s business, and only consistent with the Employee&rsquo;s duties with the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Copying</U>. The Employee agrees that copying or transferring Confidential Information (by any means) shall be done only
as needed in furtherance of and for use in the Employer&rsquo;s and its Affiliate&rsquo;s business, and consistent with the Employee&rsquo;s
duties with the Employer. The Employee further agrees that copies of Confidential Information shall be treated with the same degree of
confidentiality as the original information and shall be subject to all restrictions herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Computer
Security</U>. The Employee agrees to comply with the Employer&rsquo;s policies and procedures concerning computer security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>E-Mail</U>.
The Employee acknowledges that the Employer retains the right to review any and all electronic mail communications made with employer
provided email accounts, hardware, software, or networks, with or without notice, at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment</U>.
The Employee acknowledges that any and all inventions, discoveries, designs, developments, methods, modifications, trade secrets, processes,
software, formulae, data, &ldquo;know-how,&rdquo; databases, algorithms, techniques and works of authorship whether or not patentable
or protectable by copyright or trade secret, made or conceived, first reduced to practice, or learned by the Employee, either alone or
jointly with others, during the Term that (i) relate to or are useful in the business of the Employer or its Affiliates, or (ii) are conceived,
made or worked on at the expense of or during the Employee&rsquo;s work time for the Employer, or using any resources or materials of
the Employer or its Affiliates, or (iii) arise out of tasks assigned to the Employee by the Employer (together &ldquo;<U>Proprietary Inventions</U>&rdquo;)
will be the sole property of the Employer or its Affiliates. The Employee acknowledges that all work performed by the Employee is on a
 &ldquo;work for hire&rdquo; basis and the Employee hereby assigns or agrees to assign to the Employer the Employee&rsquo;s entire right,
title and interest in and to any and all Proprietary Inventions and related intellectual property rights. The Employee agrees to assist
the Employer to obtain, maintain and enforce intellectual property rights for Proprietary Inventions in any and all countries during the
Term, and thereafter for as long as such intellectual property rights exist.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>NOTICE TO CALIFORNIA EMPLOYEES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to California Labor Code &sect;2870,
an agreement requiring the employee to assign or offer to assign any of his or her rights in any invention to his or her employer does
not apply to an invention which qualifies fully under the provisions of California Labor Code &sect; 2870, which provides as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;(a) Any provision
in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention
to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer&rsquo;s
equipment, supplies, facilities, or trade secret information except for those inventions that either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-size: 10pt">&ldquo;(1)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>Relate at the time of conception or reduction to practice of the invention to the employer&rsquo;s business, or actual or
demonstrably anticipated research or development of the employer; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.45in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-size: 10pt">&ldquo;(2)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>Result from any work performed by the employee for the employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.45in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;(b) To the extent
a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to
be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restricted
Activities</U>. Employee agrees and covenants that, at any time during Employee&rsquo;s employment with the Employer and for a period
of twelve (12) months immediately following the termination of Employee&rsquo;s relationship with the Employer for any reason, whether
with or without cause, Employee shall not, either on Employee&rsquo;s own behalf or on behalf of any other Person, take any action or
engage in any unfair business practice, including, without limitation, any misappropriation of confidential, proprietary or trade secret
information of the Employer or its Affiliates, as a result of which relations between the Employer or its Affiliates, and any of their
customers, clients, suppliers, distributors or others, may be impaired or which might otherwise be detrimental to the business interests
or reputation of the Employer or its Affiliates. Employee acknowledges that there is a substantial likelihood that the activities described
in this Section would (a) involve the unauthorized use or disclosure of Employer&rsquo;s or an Affiliate&rsquo;s Confidential Information
and that use or disclosure would be extremely difficult to detect, and (b) result in substantial competitive harm to the business of Employer
or an Affiliate. Employee has accepted the limitations of this Section as a reasonably practicable and unrestrictive means of preventing
such use or disclosure of Confidential Information and preventing such competitive harm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Third-Party Agreements and Rights</U>. The Employee hereby confirms that the Employee is not bound by the terms of any
agreement with any previous employer or other party which restricts in any way the Employee&rsquo;s use or disclosure of information or
the Employee&rsquo;s engagement in any business except as Employee has previously provided written notice to Employer and has attached
to this Agreement. The Employee represents to the Employer that the Employee&rsquo;s execution of this Agreement, the Employee&rsquo;s
employment with the Employer and the performance of the Employee&rsquo;s proposed duties for the Employer will not violate any obligations
the Employee may have to any previous employer or other party. In the Employee&rsquo;s work for the Employer, the Employee will not disclose
or use any information in violation of any agreements with or rights of any such previous employer or other party, and the Employee will
not bring to (by any means) the premises of the Employer any copies or other tangible embodiments of non-public information belonging
to or obtained from any such previous employment or other party. <U>Litigation and Regulatory Cooperation</U>. During and after the Employee&rsquo;s
employment, the Employee shall cooperate fully with the Employer in the defense or prosecution of any claims or actions now in existence
or that may be brought in the future against or on behalf of the Employer that relate to events or occurrences that transpired while the
Employee was employed by the Employer. The Employee&rsquo;s full cooperation in connection with such claims or actions shall include,
but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the
Employer at mutually convenient times. During and after the Employee&rsquo;s employment, the Employee also shall cooperate fully with
the Employer in connection with any investigation or review of any federal, state, or local regulatory authority as any such investigation
or review relates to events or occurrences that transpired while the Employee was employed by the Employer. The Employer shall reimburse
the Employee for any reasonable out of pocket expenses, including, but not limited to, actual missed wages, incurred in connection with
the Employee&rsquo;s performance of obligations pursuant to this <U>Section</U>. &ldquo;Full cooperation&rdquo; shall not be construed
to in any way require any violation of law or any testimony that is false or misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Enforcement; Injunction</U>. The Employee acknowledges and agrees that the restrictions contained in this Agreement are
reasonable and necessary to protect the business and interests of the Employer and its Affiliates, do not create any undue hardship for
the Employee, and that any violation of the restrictions in this Agreement would cause the Employer and its Affiliates substantial irreparable
injury. Accordingly, the Employee agrees that a remedy at law for any breach or threatened breach of the covenants or other obligations
in <U>Section 6</U> of this Agreement would be inadequate and that the Employer, in addition to any other remedies available, shall be
entitled to obtain preliminary and permanent injunctive relief to secure specific performance of such covenants and to prevent a breach
or contemplated or threatened breach of this Agreement without the necessity of proving actual damage and without the necessity of posting
bond or security, which the Employee expressly waives. Moreover, the Employee will provide the Employer a full accounting of all proceeds
and profits received by the Employee as a result of or in connection with a breach of <U>Section 6</U> of this Agreement. Unless prohibited
by law, the Employer shall have the right to retain any amounts otherwise payable by the Employer to the Employee to satisfy any of the
Employee&rsquo;s obligations as a result of any breach of <U>Section 6</U> of this Agreement. The Employee hereby agrees to indemnify
and hold harmless the Employer and its Affiliates from and against any damages incurred by the Employer or its Affiliates as assessed
by a court of competent jurisdiction as a result of any breach of <U>Section 6</U> of this Agreement by the Employee. Likewise, the Employer
hereby agrees to indemnify and hold harmless the Employee from and against any damages incurred by the Employee as assessed by a court
of competent jurisdiction as a result of any breach of <U>Section 6</U> of this Agreement by the Employer. The prevailing party shall
be entitled to recover its reasonable attorneys&rsquo; fees and costs if it prevails in any action to enforce <U>Section 6</U> of this
Agreement. It is the express intention of the parties that the obligations of <U>Section 6</U> of this Agreement shall survive the termination
of the Employee&rsquo;s employment. The Employee agrees that each obligation specified in <U>Section 6</U> of this Agreement is a separate
and independent covenant that shall survive any termination of this Agreement and that the unenforceability of any of them shall not preclude
the enforcement of any other covenants in <U>Section 6</U> of this Agreement. No change in the Employee&rsquo;s duties or compensation
shall be construed to affect, alter or otherwise release the Employee from the covenants herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Successors</U>. This Agreement shall be binding upon and inure to the benefit of both parties and their respective successors
and permitted assigns, except it shall not be binding to Employee where any corporation or entity with which or into which the Employer
may be merged or which may succeed to its assets or business wherein there has been a Change of Control. Where succession is permissible,
Employee&rsquo;s obligations are personal and shall not be assigned by Employee. The Employee consents to be bound by the provisions of
this Agreement, except in circumstances of a Change of Control, for the benefit of the Employer or its Affiliates to whose employ the
Employee may be transferred without the necessity that this Agreement be resigned at the time of such transfer. In the event of the Employee&rsquo;s
death after the Date of Termination but prior to the completion by the Employer of all payments due to the Employee under this Agreement,
the Employer shall continue such payments to the Employee&rsquo;s beneficiary designated in writing to the Employer prior to the Employee&rsquo;s
death (or to the Employee&rsquo;s estate, if the Employee fails to make such designation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Enforceability</U>. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable
by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances
other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision
of this Agreement shall be valid and enforceable to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Waiver</U>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party.
The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach
of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Notices</U>. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient
if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to the Employee at the last address for
which the Employee has provided written notice to the Employer, or to the Employer at its main office, to the attention of Chief Executive
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Publicity</U>. The Employee hereby grants to the Employer the right to use the Employee&rsquo;s name and likeness, without
additional consideration, on, in and in connection with technical, marketing, regulatory filings and/or disclosure materials published
by or for the Employer for the duration of Employee&rsquo;s employment with Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">12.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Conflicting Obligations and Rights</U>. The Employee agrees to inform the Employer in writing of any apparent conflicts
between the Employee&rsquo;s work for the Employer and (a) any obligations the Employee may have to preserve the confidentiality of another&rsquo;s
proprietary information or materials or (b) any rights the Employee claims to any inventions or ideas before using the same on the Employer&rsquo;s
behalf. Otherwise, the Employer may conclude that no such conflict exists and the Employee agrees thereafter to make no such claim against
the Employer. The Employer shall receive such disclosures in confidence and consistent with the objectives of avoiding any conflict of
obligations and rights or the appearance of any conflict of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">13.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Notification of New Employer</U>. In the event that the Employee leaves the employ of the Employer, voluntarily or involuntarily,
the Employee agrees to inform any subsequent employer of the Employee&rsquo;s obligations under <U>Section 6</U> of this Agreement. The
Employee further hereby authorizes the Employer to notify the Employee&rsquo;s new employer about the Employee&rsquo;s obligations under
<U>Section 6</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">14.<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Entire Agreement</U>. This Agreement constitutes the entire agreement between the parties with respect to the subject
matter hereof and supersedes any previous oral or written communications, negotiations, representations, understandings, or agreements
between them, provided that the amendment and restatement of this Agreement as set forth herein shall have no effect on the equity incentive
awards granted to the Employee pursuant to the provisions of the Agreement (including any addendum thereto) as in effect immediately prior
to such amendment and restatement. Any modification of this Agreement shall be effective only if set forth in a written document signed
by the Employee and a duly authorized officer of the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Agreement may be amended or modified only by a written instrument signed by the Employee and by a duly authorized representative
of the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. This Agreement shall be construed under and be governed in all respects by the laws of the State of Delaware, without giving
effect to the conflict of laws principles of such State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Obligations
of Successors</U>. The Employer shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Employer to expressly assume and agree to perform this Agreement in the same
manner and to the same extent that the Employer would be required to perform if no such succession had taken place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation
Recovery Policy</U>. The Employee expressly acknowledges and agrees that, notwithstanding any provision of this Agreement to the contrary,
any compensation granted to, earned by, payable to or received by the Employee shall be subject to forfeiture or repayment to the Employer
and its Affiliates, to the extent required by the Astrana Health, Inc. Compensation Recovery Policy, as the same may be amended from time
to time (or any successor policy thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
on Payments in Certain Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Limitation on Payments</U>. Notwithstanding anything to the contrary in <U>Section</U> 3 and <U>Section 5</U> of this
Agreement, if any payment or distribution that the Employee would receive pursuant to this Agreement or otherwise (&ldquo;<U>Payment</U>&rdquo;)
would (a) constitute a &ldquo;parachute payment&rdquo; within the meaning of Section 280G of the Code), and (b) but for this sentence,
be subject to the excise tax imposed by Section 4999 of the Code (the &ldquo;<U>Excise Tax</U>&rdquo;), then the Employer shall cause
to be determined, before any amounts of the Payment are paid to the Employee, which of the following alternative forms of payment would
maximize the Employee&rsquo;s after-tax proceeds: (i) payment in full of the entire amount of the Payment (a &ldquo;<U>Full Payment</U>&rdquo;),
or (ii) payment of only a part of the Payment so that the Employee receives that largest Payment possible without being subject to the
Excise Tax (a &ldquo;<U>Reduced Payment</U>&rdquo;), whichever of the foregoing amounts, taking into account the applicable federal, state
and local income taxes and the Excise Tax (all computed at the highest marginal rate, net of the maximum reduction in federal income taxes
which could be obtained from a deduction of such state and local taxes), results in the Employee&rsquo;s receipt, on an after-tax basis,
of the greater amount of the Payment, notwithstanding that all or some portion the Payment may be subject to the Excise Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>The independent registered public accounting firm engaged by the Employer for general audit purposes as of the day prior
to the date the first Payment is due shall make all determinations required to be made under this <U>Section 18</U>. If the independent
registered public accounting firm so engaged by the Employer is serving as accountant or auditor for the individual, group or entity effecting
the transaction, the Employer shall appoint a nationally recognized independent registered public accounting firm to make the determinations
required hereunder. The Employer shall bear all expenses with respect to the determinations by such independent registered public accounting
firm required to be made hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>The independent registered public accounting firm engaged to make the determinations hereunder shall provide its calculations,
together with detailed supporting documentation, to the Employer and the Employee at such time as requested by the Employer or the Employee.
If the independent registered public accounting firm determines that no Excise Tax is payable with respect to a Payment, either before
or after the application of the Reduced Payment, it shall furnish the Employer and the Employee with an opinion reasonably acceptable
to the Employee that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm
made hereunder shall be final, binding and conclusive upon the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consent
to Jurisdiction; Forum Selection</U>. At all times the Employee and Employer: (a) irrevocably submit to the exclusive jurisdiction of
the state and federal courts for the county in which the Employer&rsquo;s headquarters are located, whichever may have competent subject
matter jurisdiction, in any action or proceeding arising out of or relating to this Agreement, and irrevocably agree that all claims in
respect of any such action or proceeding may be heard and determined in such court; (b) to the extent permitted by law, irrevocably consent
to the service of any and all process in any such action or proceeding by the mailing of copies of such process to such party at the address
set forth in this Agreement (or otherwise on record with the Employer); (c) to the extent permitted by law, irrevocably confirm that service
of process out of such courts in such manner shall be deemed due service upon such party for the purposes of such action or proceeding;
(d) to the extent permitted by law, irrevocably waives (i) any objection the Employee or Employer may have to the laying of venue of any
such action or proceeding in any of such courts, or (ii) any claim that the Employee or Employer may have that any such action or proceeding
has been brought in an inconvenient forum; and (e) to the extent permitted by law, irrevocably agrees that a final nonappealable judgment
in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other
manner provided by law. Nothing in this <U>Section</U> shall affect the right of any party hereto to serve legal process in any manner
permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall be taken to be an original; but such counterparts shall together constitute one and the same document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, this Agreement, as amended
and restated as set forth herein, has been executed as a sealed instrument by the Employer by its duly authorized officer, and by the
Employee, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="font-weight: bold; vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="font-weight: bold"><FONT STYLE="font-size: 10pt"><B><U>EMPLOYER</U>:</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 10pt"><B>&#8239;</B></FONT></TD><TD COLSPAN="2" STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>EMPLOYEE</U>:</B></FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">&#8239;</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">&#8239;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">ASTRANA HEALTH MANAGEMENT, INC.</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">Chandan Basho</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">&#8239;</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">&#8239;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 3%">By:</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 46%">/s/ Brandon Sim</TD><TD STYLE="text-align: left; width: 2%">&#8239;</TD><TD STYLE="white-space: nowrap; text-align: justify; width: 6%">Signed:</TD>
                                                                                                     <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 43%">/s/
                                            Chandan Basho</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&#8239;</TD>
<TD>Brandon Sim</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">&#8239;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&#8239;</TD>
<TD>Chief Executive Officer</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">&#8239;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">&#8239;</TD><TD STYLE="text-align: left">&#8239;</TD><TD COLSPAN="2" STYLE="text-align: justify">&#8239;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="white-space: nowrap; width: 5%">Date:</TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 44%">April 4, 2024</TD><TD STYLE="text-align: left; width: 2%">&#8239;</TD><TD STYLE="white-space: nowrap; text-align: justify; width: 5%">Date:</TD>
                                                                                            <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 44%">April 4, 2024</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ameh-20240402.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaOBmbOdzZR+aYkxtmB5bRl6byYvg5eAiSvd2KMGAT8N -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:AMEH="http://apollomed.net/20240402" elementFormDefault="qualified" targetNamespace="http://apollomed.net/20240402">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://apollomed.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ameh-20240402_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ameh-20240402_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ameh-20240402_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ameh-20240402_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://apollomed.net/role/Cover" xlink:href="ameh-20240402.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://apollomed.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140503316196960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  02,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ASTRANA HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASTH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M$DX>BW357-RXAN?YYYVKSH B/%<5S]4I/$]\+6QI0](>6=J8*5PG6"R?@L>
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ W:6$6 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #=I818
MJ '2.N\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #=I818F5R<(Q &  "<)P  $P              @ '-
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -VEA%@\4'7(400
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M2P$"% ,4    " #=I818)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #=I81899!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2410938d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://apollomed.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ameh-20240402.xsd</File>
    <File>ameh-20240402_lab.xml</File>
    <File>ameh-20240402_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2410938d1_8k.htm">tm2410938d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2410938d1_8k.htm": {
   "nsprefix": "AMEH",
   "nsuri": "http://apollomed.net/20240402",
   "dts": {
    "schema": {
     "local": [
      "ameh-20240402.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ameh-20240402_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ameh-20240402_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2410938d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://apollomed.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2410938d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2410938d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-24-043762-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-043762-xbrl.zip
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MSH"1M <8AU-P'\M>+)HZ%L!2J#Q0&Y=!MGH+0:Z$)JX%0J/]Y>L4BT-.*0_
M=QC$NH>%PT))KQ:% )BZYB*X@CZ.J,[D5X0IZ1/P+:2P&( R4R9#[,%[<MFL
M8L:X'FF]5ZG%V,*0Z)F=&K3)]+@J.(5[G3PR![U3:V(8KWO)]<5@(>+7K>0X
MIY;I^= GC,2QTR4J(MNL3&0*U<>867.7P7FE2()_Q\[B<RA :GI<4TL;4GX*
MV<SU,/4BNA=UEM\F9FK/WF3N%6>[U($^BG>P:J:E;DEB;D$KM0T%].N6;O70
MSAKZ4Y?MZ&G*(";"AAV,>[3\IM+ F0067DXE=T=H$1Z"4$2/]-Q%D*1.E*%_
MGPN#3!QI(?<?5DYQ;]?*-07H?RRY9?3SM=;<Q=72S\OK5]/E<J$0RRWRIHLT
M^02TN!=+;:"8)SOCV<9D%TMVN>A,I#_+=)<D9F]@MR0RWAY)K+G.5\67Z^#F
M8$:HO&W0-9^%C4%7<ER@2F:6O5.8_XC\10ZQS$Y)++335\(U$D:T9.L^EHOK
MTWF/&3_+O8; XQ%3XFV709BG9 _[=6/V^=^N$1D^:8+Y1[!OV#VF(!]\U0C4
MW$1-'_\ 4$L#!!0    ( ."EA%BA1)H?_0H  ("&   5    86UE:"TR,#(T
M,#0P,E]L86(N>&ULS9U=;^.X%8;O"_0_<-V;%AC'$P<MD.QD%QE/LC VFV1C
MSVS;1;&@)<810I,!)2?VOR\IB;)$\4A*BI*<BQF/^![JI?B8I+Z./_VXVU#T
M0D2:<'8^.C[Z.$*$13Q.V/I\]'4QOEC,YO,12C/,8DPY(^<CQD<__O#G/R'Y
MY]-WXS&Z2@B-S] 7'HWG[(%_CV[PAIRAGP@C F=<?(^^8;I56_A50HE ,[YY
MIB0CLJ#8\1GZ^]%TBM%X/*#>;X3%7'R]GU?U/F;9<WHVF;R^OAXQ_H)?N7A*
MCR*^&5;A(L/9-JUJ^[C[6/XIPC_1A#V=J;]6."5('B^6GNW2Y'RD]EON]O7D
MB(OU9/KQX_'DG[]<+Z)'LL'CA*GC%I&1CE*UV.*.3T]/)WFIEK:4NY6@>A\G
M$VVGJEF6)AWZFI,T.4MS>]<\PEG>[;V[0:!"_6^L96.U:7P\'9\<'^W2>*0/
M?GX$!:?DGCR@O)EGV?Y9HI0FBH11N>U1D >[&2K$1,5/&%GCC,1J1Z=J1\?_
M4#OZ2[GY&J\('2&EE'R [3IMU%4&35R;O2,BX?$E>Y]K,]J3??G=$=G_T(!Z
MO/,F+'F&Z;O,UR.=V[XA[SOBASCW1UJ.\^1]1[H6^7^QG;4MO_GPVH\K51NO
MY:>&1;++Y 1&8FU25=$Q N=[R">&LNZJ=AXUZJ5J-.>BW78U,^9UIB0Z6O.7
M24P26??T1'T8JP]YL^5__IAQN1*X6*69P%&F:\J;<3ZRE$],2TIY(;0O+**>
MQI6*2<3EU/2<C6EQ&(OP!\$WUMV6K>:6PC_HJHHO#HO<!6"T(1,DY5L1D3?U
M2MTM=)1*1QLJ%6I)1=CXZV+T0ZY!OVO5?SY-#K4XZ&BY!-IN",N6LD9+"YK%
MKKK99DKW<KTLB$ZV&#+[6$N0TCCNX NYXUCM_(KBM<6^4>ZJBZVV=!\W"H/H
M9)LCLY<K#5(B7]W\A:212)[5<KZK'0V9\TZWF&SU?4T3%@)M8S )-:VG@?V>
MK!,UM2@+ZOR6J(T=PQB@=SWT=]HVYP*K. AHAC@$9XMZ$*JB/'%TP=@6TWOR
MS$47/DV9:VIL)DU8ZIJ@&+$8 ]$HM*@0>R+BUZT\8R>"[GNA:"E=<P%8-=$P
M9$'18?<& E+)_3*R%)BEB1K >B%I2YV?;@!F6Z<>ABXH3@!S\"E)I?=+RN*1
M4*KN!V#6/Z#8Q*YI@0V;O+2501$#V@.9R2-0&1(.-I<O:G4NETD#&UO3^X2G
M9;N+GTH<+$*FPX$4Y6%(Q7DBJ78;HH>AEM(U/8!5DQM#%A0Q=F\@*X4<Y7K_
MD%RR>! BE<X/((9-.QZE*$ XFL[ZT)!JGV!<)6F$:>'E2FY+.YIGT;H&!+1K
M0M(2!@4*Y Z$I0C0S.0A7H'Y%\%B&"XUI1]86E;MJ%2R $$QO?5AHO1>()EM
MA6BXAF<<6.KLIFR/V>K^+* + I0><ZV[MH6\ 8JG&>B294FV5\_3W6PW*R(L
MC6M+7+$!F=-,F.5!L "8,ADH9$CI4"'TTO/Z+@'+U$.,8'-,F5L"[":;%#0U
M 9%@-0;0<-#FSY1Z(6(F1R:!Z9S%9/<SV8/M:NG<,@'8;$)AB *BPNX,P*(4
MHUR-I-P+&'<BV6"Q7R11SU31%KI% S+:9,-4!00'8 V@HU2CQ7SF<R99XMT\
MEJ F#TGQ/'@/):#>+2P]MIO, .* T.EV"! D@U SRB=(<Q9Q\<QKCSO,^%8.
M@/L9C^$52D^46Z@&-:&)5F=(0( -\0E@U@C]4#R3@KAZCR>O *D:O!!W$<?R
M0*7E/]<)(\=@^ZU:MW1UV&TR91$&1!+L#N"G5'[0'Y"*0;<L%&BF;VCJU#\T
MTZ'03(.&9OH>:):O/!!H3M[0U!/_T)P,A>8D:&A.W@6-['BO8\U,?KP52_YJ
M>S@;5'I!IFW5"LQ!%AXN+6]]L*@ M9Y1(3XQR1=6M^).\)>$1?"2&9)[ 08P
M;:7&T(:'CMU@'S_5@EC'>1UKBD5Y[Y=$R_R,,DV3]B&FT(0'2=-8[^!2J'TB
M<<?3#--_)\^=)^)VL1<\K(:MD#24X:%BL]<'3!&#9)"/$^L25W5#P_HJF5'N
M[A5@BZW#*\"UPB @L#EJOP)<7#TI1*Z[63$J" 9&A&:QLTZVF*KZN%861A>W
M#;5Z./]>2XV/+[+*[D+O'CF#'Q!H2USU-&1.][99'D2/ Z;,7L]E*-=YNAJO
M,DRD]N&[5N9L9C?M5!.Y+@BB=TTWK6E:ESONS=]$DLD]S_AFLV7E71[;<X.
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MV,X=4TD"PL/FJR.#C$!:ZX6%Q093^GF;)HRD\$1DJ-RR8+789*$A"8@%FR^
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MU2M *_6,6%D%^EU5@O):;+]?7M]T+3_)S7J3_&N%4R*W_!=02P,$%     @
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M (<#R9, R%PB_Y2V+4^,/F)BUH#II(N.1#FAGD\N.:#\7/9LI>O](_ @B)Z
M QPR6 _(% EUP*$ZKH'98\\>DQXS[3N<*18B TBC<$SZA@GR3@R/&'@:30<.
M^#;QC%%@^M1B=N"9$^)!;.[U)[RE;&#WH&,1LHOM%.+&H&, =%Q"K4E8UL<3
M9G?8#IV\@6FCM[T:OKY=I+%<5.N&]42@)BLE^P*SQIE[\R&P+Z[AP_)C5A]8
M,A?SLCW%Q[%%:Z.+K^JA^>A=D9YMFXQ:_%C7E ]) 8V9PQ(+WMAY"--9+*.-
M-.>1;)=#A*DGQTB<Q$8DVCA24^M2+U A$AN#N!^X5MDDK8-+HE;+1:BXT@SX
MM[X\05_";*$+SDZ#];,&IV!?P<B:<TX2? XN]O9KW>^=1X/S]RE+"DZ>'=.O
MI2GQ^$ @Q0!GU:12HX6*FM"4U+YYI">U<E'4_*TJOZJJA.#/A<O0?N,!5GX"
M!H,,%]+&>9F(>6,>;JJ=+QOM_BI4)K5_,']LOY;JP#@+6F*@#WJ;2DTOJ&N]
M]<442=3]K4J_JBK5LE6IXWD!<Q]4*.OS1NWV]'-PY*]$H>KW*-3,"-^Z6E59
MH;:F+:96LNZ+J-6SII:YY+DUD=8Q%Q)#9_9P':EP*R/3/&#!BK*ZIY-[NX;G
M7KA%%IJL[V>4RCF)MI7$27&UGGE*(&X1'@KG&,XCU>L*[\&)@WK:D&@F];S[
M-/OMSM.E2(MT)Z.>;:YY]^ZFBHDL,X=Z^07F$!X=XTO%0IL&"GXW-."3V H\
MRQ[[(DL]]UK"LJ*P:M;-S1&%$9U4U![7A&SOW.M[E=K/L[]/W:W' ^^IS<[I
M?G.[Z))A*;N^K=T\XF31/WJU#N1J2246.IR]5.QOO_-]<-S\V5H.^4HM56H/
M-]4I/U)Z]/CU<8W!,(O';WV%6E/Z%$9<\X\ LT;=JGTH-WJ;3SL2B78P:T=:
M;63I6W)<X!0@'CJCGDY_"KTCI]2]83XY.6DM?AAM)>G7JK8>.I:.D3,CO0G1
M^#8$M+H!!\+XP;6I/0+#([#*$'8CX0$9N/:=/U0@ '=PWX!Z1&=]PQ*'E@6
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MVX@=W2G[,QE\#Y,2^_</DK7*2*AU79!1"=<;[I@$ ^-\J QC_/7R$E!"-4I
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M^=3%T15Q)Y<HC),OH"^LHGCE^.G=)4NQ J^D$?,.<*96"T[^]A6E<*C=#MS
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MCHA_#D__L[KZ]OX;K1[V@4B,Y-I41#ST(8?@([F"I@K6JY)&//O<?TKJ(+E
MU4+Y1DHJ2(<J*?62?G%HNH/)!L_$KDJ9QULX^/IU%0?\5<+[YU_2Y#K-B%/5
MUI*@M\^WLD&\#4*V ^2D!Y'CI)D)TGK$=8./\^<)&AICZF)&#Z%(,S@Y>P#D
M#4;( Z2@"4L/:Y_/$&^!),%OF:$7AV23C$>'"*V[<XQ#/#Z@@_]57+>*ZY>0
MUC$]J2+!]9I%C@$]/ZG4IJ-B&]+*>GQ\(JY(XHUQ6"ZG*4Q[/1\*8IG'O)*4
M__/\69 ##I"@DSV45TF+C\2&;6L\/RA(+C>[3%)@Z'PH])Q^M EV]B:"=(MM
M=MOJ#\G^=R;PB7[3"*'MI2#7@&MY"'(]&**HN*!O[7M"PVYXR)^+77V&[6-
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M[&T4WW!1HJRB61PIY]FX'';^I@C:O@>)-9-"X>/((LM#U(EI\%PW>HZ&8.C
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M<IGU9.^/6E>=4>,&*A)#8&B?]BGC4U*LIC:1<K!V9GUI#!Z+ [\4M9]*%NF
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MAE5,>-^'!78[T :-%V93H$(8E9E;?-#1,$"5AES;$;QT\/J@@GV\[LPO[Y9
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M8PADV(0G$.X#'.WP!99P'11@HZBE8J$1>8EB@IRE"A,ETGU^>N QA_FKXA?
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MH373)&Y$SF]4@(37=6.H_O$4M/:5?,VAC8AYG,)4!UDJ>MV%,1LS"(\,29B
M..YN6Q*B:"EN(>BZFK!M,]:.I<'Z,T($+%4S#_  V9K'*W&BCB\,-LVM!W3!
M0BEY>TP[4;N<+'G&AX=SNLC+>YC\3I^1-1"0%*T =^M)1\C.??U)/'4$$9&
M;+! %I[E$:U'-HGP?K?2]2O(( :0<[2APWR6V16P#W63]TMTDW(E[4$'4TVM
M%^=)QR6F"6T.YH)8E>/'O0R=[)'E=5";[''1H.'%2TXBKTX$?67R-WFJS6JQ
MD['AKIGL%>!>++RP]7.BZIQ1Y:31[Q@F736ZMK8I%<\K_EMLIXGUSGW8;:>8
M0!V:XH!@6Z+:,Q,/1Y^@5T'C^SBQZ?%0T [E&MTVKKF5BCC3"V"0$@VFM6EU
M]C=_)%$24->S2.63D8(9"@1 T?#-B&#9#OY./<!W4OV[!%:/;G-@]>AK8/4O
M(,9;]_W[/V/!G 8VLI /O&"[EVCVV!QPJ.1-[H9$OAAVS<B_O,PH>566:LXE
M# % >2>?D15T)6%*K <N6-V/= DC1!^B%W/K(+ "'YO'\!YFN %<Q F7Y&2M
MZSZG$;79PE&^?%II9%20U:ZDGG@JJ ERH\RX)-1TR0+#L\Y!6 HV^_QUE$L"
M(UI8PBU;X Q#CA[=.MV_]=#\\&<.S>\8=FSDL( BI3!D8]Q%MY5"DNOB$20+
M:,5+EQKB;?#L!#))K0V*FXJ/MI$--D;QCA>T&+T._T)5<J9N800"97QGAL18
M[WWS.9(I";T7QU4&$9OXNQZGL TS4T)_VM+%TL7>M24.CL?5L ;! #I")8+U
M]1['0_DJV;YD']W;1;1CBEQQ8+$"E/& 1$M.)-=$(+.T/;]83T;,1!94B%X+
MB>ZX!FM[XH:E2-",VG;ZHB\]9MAV9C^-LP$<^FO4',%+ CG/%6A/BCPA\5%*
M.00T#0B&HXMT8/^+WU)F&-\L"HJ_S8RO&H&Q&#.Y$2@9)H &=CJUK4+GC(C+
MB0Y7V?%D76>*AV9Q>Z:ODAQ(\M$5E+37,8-0@<Z:&4LJS)ML'*KJI5&B=*=S
MOBKD\D-YQ9("+M0TGK1)!!*RGCO\9F+&8.V(-M&?(9R'B)%RQ$K!8KY7W%[<
M@TDQOS =P;LA:MAQ\! >DEC\IP0\&V!:9YS<HPJCS74^,<C6AMN_2J<OG<<?
M)9U8GE!JZ8;^VH]-;<.T^TD=O-<'D%"C1@W"%UM(<$2=7S=:)N2%'$9!QUP[
MDAWL#'U." 3>2-8AYKATW7H#%+8IDPI@RR&WE#0OJRS!3C  07:*!^)5TF.(
MK% 44$07U2OG)SK.>A,U+L$Q#Y/7)KP>1XEPQECQ+4F##.%\)MW.R\TXVQ$F
M)YM+L>1")EAC'X&S"2H_[?D+=)G#)G)#&0[V6+701NSMFRA2:Z(3Q30Z[<]Y
MK4U#(3>9$$G(#H@!C%NW2V6-;VWZ7S;XEJ\*)% @]Z]NJ,T\WQ:':V2!5480
M>QV6O90J.U>2?^0(\:"+K6DYJ,NH!R'\(@:L#W12;.M[P=G+L ,C;<6W8 2\
MJ+8AZC7);U.2UT87.V&F,!4^?J/#4MKA9E,3$[]\Q"!/EP_YJ]3[4O_@:E)_
M2E0MDSV[G*.9-K^-+6=QB>@N\Q(8[O8S^;6XBS9=#$*OO$0SO3$>//GE/7HD
MJE!M5.!32TL.UQO6=XU2$*XYB)[YR19*F5^XGLIHWZ66W(]S#MZXE^R>^:R=
M@AH8][5<M(&(N+%1A2+*F6[!?2W,@&W/BS#TX XZ D/ 9"R]\U6(6],,B!]O
MG;CODF,XOLTYAN.O.8:;+\9'#Z_BSOSVY 0T1A$0%@=:2++-V9*[2:(Y3WI+
M2:\)BOT;!:0)Y7*9"J*OQ%K(5Z?GRJ*H;JLR.OKN:KOX,W5M(E_T97:Q'<3B
MP$BF(Q4!I+GQD_1*XHX$>*&V9@^Q>Y(Q =]UDN=_KLJ,":5-Y&1.<>[)'M]:
M7A]3ZT70@\!;K'*]*ME=(9^''GKK-OHJN"78Z->^_P8K-T0NC3B6A@9I[5!'
MR;[AY^8N7NPE\+]3W/)5W^2+#,&IA 9JJ+4W74\VM&]A:P>4MJ &X8U?.8!'
MO+1=PQT516/A0W$!:NV!PN$SO03HR)"BN 2G0P9HQ(I!,A0.@-VI1*R-,8B_
MEG3:D-3?E@AX-$_V17IF'7H/K;3("J*FJ9(57-VW3VBODJJ6YAH&%#G9>ZND
MI/8-46"-1,D\&=A2U4,M)N/NR5L3L%%3Y90=@ "R20%EJ>6T//*I1=MS,;JI
M(QA<;V/=74",9DI3$3:SXS ,*8Y9CX'=;:Y!9-<*J+SW!%D$JRSY165EMTB3
M%U5^F/B+G41KG9K^-')0@KL=8:;();[DU C^=U_*=9S:$-HRBGMU]:T#(AU=
M)=],O .&/0<3!V!,"P0-%-8S[NV;G%+U,YV"V[*8NU0:9M?:9LOM6^)MV]5[
MMH>UV<E]TF%>J.GA>*@)-),VJ #+:6%IO )67 <!IFO,1)$'5>)."P: \WVO
M^0*_*NJV8#FS7&@&S'?Y%L+_\P7^2L9IBLQQ@00LCX0ADM$PLS[^_M[/YNY'
M!N<#QVZ%8%%.7R!,!QU><#%3(K;P="KKQ!PGT&4?D,&LEN(5\XH'/_SP@_^*
M9!__Y29[RM\^RS[X\Z5*G(B!3:"D6#5)9@Z3H1&^%7N12$HB*-+BU\IZ,E@9
MF\-'B6S#52T?=QQ^5!=0D2-$?5J8-$N>1AN"2.T/(*+_WI#9I(S$'5P:4P?W
M([4P,0^A#F[.,C-1-AI_//S]S%LV(A48$924,CW4T\1*[$P:QU&<+GYJ6X^(
ML BOE*B4H%80!V6^ GM,X'#K:C"A1R@6DSVWL^'0WTJ[F+'1\TZH<Q?DQDV=
MU[0;2VG$! 8?=8:MB/V#"@Y]J!J.+.3)X"N=B3+ VZF7)*W*RR;Y0RU+TQ',
M0K,7>K[ %6 %BW0;!!:NE%U.$H-^Z3$5X]9*>V'_G:8 ,S?&;D2H S)MGF#\
M,4=)RE.@YQRD4@+7;BR&H5U<(02)2%:=+%)3E-3Z]G.J36W&Q6YHW-D&+>AC
MX+P,[,X7*S%I(E7AUOF65,SL<L%.KX$<&:U\OT[,0P()!Y17R8NL;PE3I T+
M.O&.F*N*Y#SK"]V9SM)4V2FR5&3K *(_V2N(V@C/-[60,F*CN=* 5?W2= 4V
M:EX21;Y[B$4RKCUT1,.2''TO>3S#%#XVX\G>ABFW]<99TYW8<%5V:[Z823MB
M7 4/+(+>_+DN>E1'\Z;N5UXYD*043+,<JOK@4LAT[/(##8>=LD!+\%J09X^%
MF/.*@G=7VU*3**<="I88:TIEC=&_H,4=#6E,P37C1GO"RS.: XKV;VHIB78;
M[62/ACNV[6YT7_6)T2?Y]1GL'Z]6-LNBVV.1.<,_@"XZ7(=Y+[R]F$XWG<Q(
M"@LLV\=J9:3@E0[W)C67R1F+888#>$DGF%KTPK/60#C'*]O];S+J?[/6V;0@
MUJ1M+1#&LTZP.D\B(/%!R]R-+:3/;!$SR:PM#(OP_/BKR"!+7:'CK&\JW8[P
M8H<.#Y.7)?5*5_A8CXB6&6RY,'Q B#"<GFDI9_R(>(ZT%3),3M[.D7YXELEV
M^V(CDXO65UK[Q3(UQ8NH0@UMBCH%WI.7?4OX\I4U<"C7?:OTS2X)V?NW.2%[
M_VM"]L:*L(37CG="\?NA<BI,)K7UGU[]U*/DI[H!1^\=M1:V%%@G[!(1D^0P
MTVITYX],>MXTZKS.24&"@[34?BA%]$U \V$0(<X1-)XE%7LYKEU2=13O&A:5
M6[=PH3+PMD&-J88+N-&K[#"$XIQO"T%U163BRJ$")21/4%06T7AP81C&.TB5
MP@<I\-0;3A_FVC>1NK#FA:+OW@I)RLDXG8Q-)?Y,<S'X'+NC Q!G%";>%%(7
M8>)&3-_._G@#YPQ#7V&L/R[[2OW14=_YULLBD%?@0)NF-Z;T_C7+M'FH8E4L
MA7^%ROB8O]?4WLF3S&THU4J&?U_*, )@4A1VW _BCG1?(X/8D*3T )8CO_IR
ML&]!?"-N,<RP10;<DK=V!R1=:"]DJ58B?U >1+>PF[:5>^MRRJ-A/486%Z93
M7&DZ0H=%$3M&;/\ACF5PPN$E 9+98+?)I2NSM6SDN<(*^$N%5=MF?]XB>9V*
M#1GQ2-AN?" +I+W=_D[+$>%Q%E-;'H\D=X9J[Q''A]75EM'+%6+_(+*TD&^:
M0,[, ?Q'7\Q]_O7-8_7A$T9;XJ#DD$M!'!ULKJSR%94XGUA]*KMH7\Q48XYL
M3L31%BU)T2=F'1:R3R.LK\91%]"%+7_Q:PL3SMD1LSF#^[GP-5(29@"WO.ST
M^.CPDB9C5ZL6Z=%4Q'UHMP*MF$I?4#A8Q-<OIQR5SKU'I(DIW>0+]P*S%A@W
M,M\.J_"L[#)F@0,9Z#F!D."A $\:\R[FX-O7V))P<6^]%!"V4#<>&263C8?[
MF>7D2[66_;_O7OS\ZN3LM[>GR9N3GT^3GUZ_?/GZ]W?_[Y.]]M-/9$>/Z<%M
M]I@>W&Z/*=9:UZ%87[Q*?G]Q]NKTW;OD]U].WYZ^_BD=9K\QNBVP%&Y.3SY(
M05W;K8W)?%.I,R.<^F-VNJPD16I!J7'L#'[61#(TBH@7NMT(XY,&^87.9!*R
M:0T7J@!A;\1=>7;R].5I\NSTY<MW;TZ>O7CU\W]\<^\;^OG-R?/GYN<K#^]"
M%]T"/WKO'U8)Y'599JL6#H7YUS<DRH_/WIH7G&.5=YZ59BIP8+XQXG[V/'GV
M&D?YZC^^.1X[]K-LJ<OUCY<-;:@BJ#^XM )_B_?NC]P*7([ZV7,W!+=^_F^_
MQ,!.1P<&__?V3RSBZ&QVF*/_B3\YA$^W7"?OSMZ>O#I)?CD]>7GV2_(K_/OG
MTU]/7YVER8M7SPZO?S^?-J IP+)_IY=__3V43\E!?_B/3[I0\)W1[;)W[%:S
MPJJ?!_<_Z;#NMG>)NJ\ H_AIUB[JK6.4,1S_8\,619_[[I,.]1T55GRB57SP
MR5?QDYV$#=+_Z49[^7Y_]J/V!>:(%/.ON05,-4]>2ZT?VC4_@>=7Y<CO+[^]
MGC6X 1KO$RXX\E_^J;/Y2:_-5:/+Y$&:'-\[?G"%W;UUZ^%$YBY9S==NNW^A
M4,##1Z ;*#[Y8_(2Z91N73S@X97C 9_?-_^,(::[3U\__]<3_,<O9[^^?/+_
M 5!+ P04    " #@I818&%;T-[U-  ""H $ %@   '1M,C0Q,#DS.&0Q7V5X
M,3 M,BYH=&WMO7MSU-:V+_J_J_P=='+/6M>N$@;S6DE@4V7 23A%@ O.2:VZ
M=?Y02[/=,ZBEWGK8]/KT9[SF4U)WD^!@,*MJ[V!;FIJ/,<=[_,;C7\Y^??ED
M?^_Q+Z<GS^&_"?[O\=F+LY>G3Q[?YO_"7V_+GQ\_??W\W\F[LW^_//VO[^9U
MU?V8'-]9=<F97JHV>:4ND[?U,JM2_D6:O%.-GG\'+\*K;\Q[RZPYU]6/R9WO
MGORSFK6K1X]OOXD>Z=2'[E96ZG-XK-'GB^Y1XKWU^.F3TP\+/=,=?/WH[N/;
M3Y\,A]CA*[LNP/LX/'KG4>)/+U=5IQJ>U*]O7K[^]Z^GK\Z2DY_?GI[BO\8G
M]ZF_?'"R5%6ABB2KBN2M:KNLPQ_:I)XG)ZM&E\G=-+E[Y^[]P[]A/E>ZW7_T
M;:?G:_FEAD7CH'>.'NCJNR=G"]TF$P>!5 P;U>$C_RR+_^[K1X]_>W)RWB@%
M>]<]OOW;DW\V].O#9+:FC9RI[E*I*CEINR:KLN07E97=(DU>5/E1FF3)<U5F
MEUFCDKQN5G63=;JN$OB"\CYPNER5]5HU_OCI_AX._VP!_S^KDJ=9NZ@GWE/X
M7BHOTJ2Z^ES!HTURJ;M%@B^93Z0PC[)4>:<O5+E.&C573:/P#:2$</@W6=-I
MU<:S0BIJZ3,-$Q'_T/8KU;2J@!]UE>BN36#'=*.Z=9JH^9P_.49N\:J$-''#
MD^?PC^#[,,6L RIJNDQ7^WN\+'K4GM+FDTE^A7^?TX-\2,G!O&Z6JH'=>%_5
MEQ5.\16\6C?ODU]5H?.L'+QSR+OL]E7M[]'$:F!$NLI*&&RF<M@J;^EP[KSN
M8U[XW://0?Z?[^+]_LOIV].3=VE CPG0"Q!)"_M7 VD"Q52]0FI4]$"PQ[B#
M^#,PD"73'+Q0:+Q1;=*J+H&#A .>J;*^3 <GE,"=OM1EJ:MS'+]5#9Q),!48
MONWS!4QEY ,W[+!>O?X=AL(3^^GUV],4KS3L1:L+Q2QL?P^N,>[>LN]ZN"%Y
M?:&JK.IXVS)S%ULZ4[BJP&* 'RD8!O]>$W,ZKVL61A=9V6>S4H6?8$)I5*XT
M3)Y9S'RN<ZVJ?(U<Y'*A\;20N>+8>.USO,*E*LY5P:\+#^,9X=6> _NK+]L?
MOY[CC#YR?/3/_^?[N_=^>'05_[%"QXC#3WXMXBV3[_Z=IW6,'W[\TVO0#+R/
MW6KU?Q1_\;LG!]GA\(%YMM3E^L=MBNX5'L_H?U"IP;D^,?^!,ZS.19[1O7K>
M&SE_Y+AANP QMI4EPXUZMM!JGKQ>T;4%YOH:+RD,P.H+_NTG$(E5KK-R?\_\
ML>@;8L0PUAEPVX2X"7!H*\53_"*,B<*9'BMHDDD.1P:["G(4KGO;UC LJK&D
MZ"#WAI'P"T8GP5\0LY'78;[+;+V_-\.IMT $K/L$:YHW-7P2SHS^@O\%UF+V
MY9]-BYJ(6?;I!Y7W)-[]9;\!B::1F([<J)9%Y6H%?)$EC7+ZB_>-I%\-1%W;
MS_X 12)A,3F4>KJ*-M#[-!]EHT#_I &>@CY4P!?>Z67*ZP!-:N>%\&B%NJ@[
M6!5\<@8*&^HY,#I0>?L>A*R(@9DN-6Y[BK(U2^9]6=[B#<U:#;]5'_*R;UD5
MY5,P*IVWT3-XHE)MZTUA1-JT., \ S+ K\ ^%[CAI-?"(_"[.4R+"6)5ERA%
MB!A0>*"^.2MUNP!:L&=/"HDY?#R*IW76%$BGST%?R;NZ:6/%E9X(; 14=4?L
M@C&5\V2%@LEJG+_490$7I 6%FQ7. \\>"88,/]B$*HWWUAM9M?_\WZO4'%]G
MAC[[ ACZ""=_PQP2V*M":H,971#W@U\F)W"12V2/PMI? *$5S#D,SUN%K[?^
MZ\YD#*]^RE<#WH8]1L[5UL!;_KO7:$=Z7 Q4\+)U/#P8&\U#(4TW2V/!'L!U
M*-2<E$9@:[#*=VA"P:P?XD)8P4=3=-74%QH]&F1[T=VV7V&3&]3)EN9H#>'W
MNBJ"I=K%R41;O$0@(^ S;EF>+/*W)NF!PAJT_4+.^V(^,FQ6K<--P%_8U<>[
MG%1UAU- ([HK>0JD"Z,1#2_F]7*EJI;]"3!8HY9]995S'1XU[GB5E%KUB:CM
MP>MLR[OW$[NQM+Y(L! OS_.ZQW_.HVV?"P>RZSK:WSM#/=SP7#3!0/._4$UE
M5VQ9_80XQ/DAQ3A2H>^0_A_8=UG[7@Z+%V#GA<0/EH)L2;I-DB YV4=HQKM)
M%O,!8."^D!%J\N3,_MZHDH$[-S-RIK!R!GX(:&5L]9;,S)+3)+RE[HZXJ54%
M7:)<@3H&/Q=Z/H?MIJDA?<(J]9!GV*/,BGK5A7?^FT"Q B7_ @3*M%QY52?/
MZFH.)\TZ/=#M.?&&T$Q %KD"TE'F!EUF34/7"8C%WM_P/L$]9;92 6-RXP+%
M[>\!6UKJCCP'*5 X.S'1!FFRG/P,0):DSU_J5HDSD,DTYO4#WN)_:IRMR40O
MZ[[D>\'A S-2ZD\$^$ X%;HT<@EQQP;?%P-D]-/&5V6NUB/+@4'*+>I+=8'B
M--Q&9"HK]&[D>H4\ 9799*F6,_1DS2=9"5SKXD*W=;-V?V8+B22-L 6\]S"%
M.:C=S,[JYCRK]']X_]@UG6O@,^PE6X ]UI$')W@N1=6@K&$W,A%_S'Y:L5[P
MY K=YF7=.C.,]6P<MJA)""YA=8VF+=<8/)@C]\4S1KFKAAL-Y+A"8C#&!X_%
MNQ^:>C>+79DO_H];M\ B5V7Q8_(F.U>/8-C_[A5H@/!@<NN6!/@>/W_QO\,P
MV:VN7L$C=U<VT'9K5G=@C/^8/,3?S>H&2-O^[FF9Y>^3XQ7JAZ4N8 +#L!LR
M2F]#'M^&CXY\?]:H[/VMF8*[!9-<T:3].3T<F1+.\Z._Z6W-;=P;WHZ;01Z;
MI5GQ!4BS<3'V6Y7UW:)N8#5%\EM+=L[90C?%+?0-KT$Q[!1%Q%"\O&EJX.'=
M^J\*N?T]TAJ1??7XR<;R.>-*K\2D&1=6$XKPT&C 'Y']D\ $X40Z;]XH_!&^
M,B?G#7G>=$66'NN_1G8ADU\U6G59@]S5/L$6@[<Q*]D8BA+6HGSBQV48U;3P
MUD+X/(7C83YHN9BA,%@(TDQ]0/_7F&[JKS+0]I-%76+$$>,$N@ S)@?+1;DU
M7(+P@6%P$DM- HL49!(VN/NL:L/7ZDNP< [:0_RA4?7\R'J;_HP>@XN%C>X;
MM%/18G-[Q)$CN_G!SJ+U6IU+%(J.K]&H^JB;)9/$OW_WBJ,5Z%RFR\QFJ*XT
M'4@WX7-&^O6R)"3 7:1BD\_8],K@/0PG'=P[3-8J(_+7-9[Y$E[.\6S%?QO'
MLF4:XY^7CP"[JI%6<E)Y&E7!GK.[P+<OZ;OP%97A15RMX%:0 I95E09ML<4+
M+6I@/ G004M0[(#D--T?YH/G\!IG (2W"GB89N\0WF(8 ID:.2-P8G A2I6U
M,'?] 08Y>'CG,"FR=<M438%6O(8%KCUY57?([F V56&\_RC3SVOX*65U+C@A
MLLDKV02S:'L4GDL<?E]JO*'( BKQ:K3.CZ$K1Q+&F72?/*'\:W(I'24>B7 4
M>'0&K+CZJ1,FM!EG4!CJ$\_6YXDA?[[+?>^*+_<SSXG%-LE;55(XZ-<,:+<1
M6_7,]X@S]1C_4!#WL3["@7-L!J<_1YDTC+=X!'4//[>_%X6VCI(3UC\ZCG%D
M[^&2\@N>+6C'X%F@#2.D/6KC3,]0?$V%*M4Y;L7^7A"_@ %U%[W/1G>GU(VA
MSZ\_POLT \7G75:"&)B^!%D8S&7Q!R+E ^@BG>B@^&N2/NCC-%[>!D4D\KX,
M(WG B>E#E!/R/Q_>N9/>N7,'92+SZSA*%L[,97;!=%""I<E,W[I4ZGVY3HTK
M MW-34%1BD%&F[T3\'Y3\]T6AR:(%#]L*I'C-8VQD  ;?<)3M[OL [J+<;N\
MF3JAHRA9A3(GC>@#D<L>H>"F49BC E4<1H&=J<KU#='LON)HVPF=-!QPU;N8
MVB@QMG7)OBVP$&PND^\"5;"%&A6V(*XCM)3D6;M(9O@9NC[[>WXZ:C0)&_RE
MJP&Z*1P8B"G_L:1>8>R_KU (P27]_LX_C'(X$"T^U2,-DX(YAY6(]C,0<"9O
M;CPO3W0BOA,F=8#5-&421=T^C8;L>-QPOG:G0;Y)?D"R*K.*;^ZV+3@@9REP
M*$Q'1C\/#.ZM^_#CK_O^GG_?DV_7_2N*A;Q$#S91^HL*"0:OZLDE'/I?X@$F
M*.CQ <^=SR%<,#S(?4ZFB+8?1T)G9X0,DEUDNLQDE%;#QF:87&(\[4"]RJ3W
M&-E&]Q%?=[<1WCU'IP=]\U;X35"O:<7DO4+FQ"%EC(^CPX/_!MHQA:KA#W"!
M,*(X<6D'+IY6_I* B,[?HX\L+WNR$6<]6YPEK(K465PA/@076H(,:*4W.L=+
MRG]!%N1G-O!D0!&'_909H_.(W^?X+FPBK1TO.BD;XJ#!V:-) ??^E-]\X;;D
M#9X#V-Y@3' 8-(Q?X$\T(=0U%,=QP]P=F)+'V%_5R4]97W9 ^D )I)M[_#U9
MJJSBV'0:I\^EUI8/2(P]5)+EAOSI9\RX?0L<"FL0)K,L[A^H0S_1(DPIPD&-
MF:V*41D2Y+4A&Z_A$)]EZ(O;]-7"^VJ4R:3<)P/G:)B*4*BL(\I\KEO./0.=
M=/*++7PR.TS^F2U7CQ+42-R2[9U6%^R>')^(Z,-P&IP.D(R<8"KN THDH<#F
M_A[;?>9V1S>-+U.R4*4EJ2@SA,P[&(M=#QF\,L,Z![3FVKE6\6MPU9;P,%ZS
M<AWZ9=C)(0Z3H^0GU/,O:EV8?*"B[F?H%1M;F,E,::/MJ7%^QW= PP!F8U,S
M/8.6 H'^#99@'CZ.1.TI#VA<%,1',=Y:V6Q47V.73/\Z3I8!<\#27_SYZ6T7
M>T'*$;ABAUS-5LLXK[.RG<RMX+^B?V@)"HAW37U^).Y"\1&VF4F(1&5)S^'H
MX50I(X<2YS$J3LNN^Q:V0<RR8F@)W2B%8X=HYMU'R6NFL!_Q\W+M'R7_&U0Z
M_//?$^P<5K^%P<L[(Y\@K6FS3N4OW"SY47*V7L$3)PUPO_Q1\@HHB[<%[B\L
M]FX0X#1OX5^LSO,M"'N-U>@O(0@[K4:_R71!L\(,<]:<GT=J3.R/%1O,J,BH
MPJQP%,J7J^?S$=\0^X$]MP]*3%%#1PW4*14UF"[GS('AR(%/ET:W1EL>O:F@
MQAIA\^S$*4(TRCL-S.&E0DGM*P)QAIZ+XAR2*\[_BE'T)3@US![4&XP0,-FM
M%7(4[2_EZ(YN\@(Y6;9NTS$/W)_:Y)'D?I.+&"T8<W6V+KEN?$5TTP9X5MB-
M$I*;V8GZHMG)Z0>,8*AAC,=3DP-]$.@'=J]1>CGKFU9R_N9)0^:0Q$Z+I&_1
M962U/25?046QQW ?NG)A:/C"'-]V.O:.7FH9,)H'W_)OM&EI<_[ET.:&((P$
MY78E4;_8SD_MU)+ASUYB&^IS9J0)U9B_[>^1BXARN)NLDE(_EEW:%#BDAF7.
M^ZYO,.Z"3JG"]R;%AJ1$#\WG,,'3DP%5P65>;,LX3RXF0_FNW#3P#^-;%ZJA
MS(<"F+E&#PGG($EQP<A:P$!OQ*:CTGJ3PVKWQI6&U-YT)S)&W5N@Q:/&R:?#
M3BB@R0-].!ER,FQD!4)=]TNN3%AR%5>:(,$#.Z$B9TV923G8AFC1X9)1A3[0
M.PRNJ[9OV'3T/],NZJ:[9?,4G%5;6/]'\"IN">I;^&Y5)YP$ K9K)=D;XA#'
M+(Y_''K<;3PXP":W1.T&190@SDWF+X?4+RA@Z,T,<\;@L,FEF.WOP4VN3(X5
M4!4FB72<]0MKOJ#$+,_QHSW;N<[S?F5S/LC8%L>GFTZ)GGORJ?@)=XUU+\[4
MNJ8"$#@<VHQ;<R2L@X</#AE2 \[ISQ\4'4JIYVK;<21T&MUEG2P1J@#3&HJZ
M+#-V'AJJ20Z\:[=4BMPF7@X0,0;,W\'?^QKGMX(_)V'.OP ),R)3SK(/R>\N
M?GU$7LN1X#[1 "6;((W@?X$;]KFXS <1\ Z&Y0+A=N Q$_J6M/](_(Q4;7LF
MC>Z<?K4VT7S"?:""*G2W:H5Y9_"@;H-Z.YHS)X]-3)SGX\W\"(PVGNI@#=,)
M,WX>UVAQAA75R*>6Z&MNDTIUIBJ+_:ANCBBI_%E2VML";^*@1-L-C<*R:WI3
MYD>[,!"]M".<\"NK]!>F @M+V0K#K,!T0$7[Q& T@[KY8,S:25'*$S;CV!5&
M"V3#S!N""GEDB-C:Q*P]]N;:*HW23+7@1]B-O38FY4 $X3K\6I[!8@BUP$\,
M(VNV;@*=P$[+._(Q,"%O 1ZXR(9J01@'Y4D#:Y0\4#D$G2M3]1> SO#NNEI'
ME]O-2 9-:LMW4B\G!\0 URQE'?RE4NM11S=NEF[;'NV-DN$9NEKJ54>7^TT^
M&/FP^ +DP[28<" %)T"I NG0)B^,^A$5.)C+:=0TRH^HLB7Y5> 5N5RB=;G!
M,W]PJ]O E6.O5>1;&RGDO2$$)[F.]_^&;'>)YGE)[YNJ2S!SF5F@N-L\CUJ<
MYV,BN<A8,!I 8"NQ2#/\5 G2$D7T=).#*MPA;7PFY*5KRF2^["33YQAO'SHW
M-M,9ZSR6S!S6S;!B%H>_(0SB:TF:W"21C.4_DI",S,>1Q"@U^,9_F+J(.A?Y
M%4I)<_GA#KFX:O:T5*U!-J+"%)!!*8$S]EP+2-A2=FXIEZ<;EX8/0 7FN91S
MS?LJ'PL>>4KJ0F$>M>:,!N..V-]#+=26/X]:&Z3%B8:-S-9W3^>8J5\7DJU!
M0*:DTY)C211/*M(IC"$!*KMR%7EAJ@:Z7-:</[+JF[;'^)7)C\@N_1PL,Q?*
MP6(3ZD"2+L;#5_3K9T#PL'F5SI*?B$J3MSR)D[SC2!__FLTX WS$83+[2#"(
M;GRE%=_ZI49'_3D_;W*N3I9 ]'DFB24N&0B#2O#@C>(H.Z1)W+O!&1'WOF5$
M7',"_IH3BSUU?1!J03E&*9,L+4]8[::X=YS\&;ZX790&Z9E.,;-?Y$1 D D@
MJDP.;^CD<SFK=HHF2Y75.\Q5Y;@)AGKZO!ND,I+'2W<]"DB0 !;E VOC"-P5
M+-)Y#R/IU@PQ4C@?9]9-R6,#_X&NFD:U?<EAA[)N@2"*;$DU  TF7?_18V@#
MG].MFU2$&S(,V_BE>=6%%D?9G#QHJU)E.+/S7I><>ES5)4?[N(X*AN<TT3G6
MAJ^!5#C:8-,=4[L=A&6B2CU3E)A8U=4M?_WQ+F_9#W?X![6D#V=$BJQU6)#?
MP?NKQ;HE<4W!+HIQP00Q8DYZ0[;*<LFR=JK5(>[:Q6'BG;58D<-9.Y-6LO;V
M]QYZY;I#LW/+R2:['^S%H=WL>:;+GJ&^\KHF@%,EP<P,JW.R!$O\&=V@HC)_
MRF$]MQ *L)GA[VAKS_LRZQ" !YX 32M1B Z0"Q*0U(IR2LR\HY@F.X_109QW
M-KW7)=,$\TM-YK191*'X19F2MR8"/$ 4[*(&\]PX?YD0S :U@E#)P;Y&E>I"
M]$1RS0>K(_76_[3&>VL3+6A@ ]-9!I-.."49E%E26#?.9X0+#*?2/J+)'%S
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MHWZ'GO'+&%L_\[]^ZP."M,QM?R\NGQUPU&TP ''[(?0:7,*MI80CN<7NR\#
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M,GU:4^JY:<D)K5D&%(L)U1$!26^ON#OC%;@=/Q)*F]413%H^X6H.WC@.A04
MYXXFHMT2F\01!_N4F!C2$0))MU"(.VG*4!ZC$)?$,$XAUM*VDW*5_JP'85"U
M\L?&]').B1>SE[5>;Y#&N?ML?DYJ*L/A/%P5<1I;)('?S?.OPY?(16GU%)HX
MVQR?L.W39^[GL//G[^_0Q<&0[/&UR?IZRS9>U+2-3+25J5UJ3#M(W_(TQD?
M$,<(SG-)4U"0]$XT1@NUI"XZ8!*C<FN2= EQ BS:?,'@KM8#8)M#R <P_/W9
MSOE3T]E54MO=ZQ9[><N0(A3HHQ3T40O4LC]CUYN#_US5S5=U]G]2[LT.DS,?
M3!>AO:P03#;(0,H\:;J6_;54GQ;(0%\;\NZW7PE)]?X%G^!,H:SQ4(01,=BY
M121OI)\AG!E-#21V&NHZZ&3(SM&;W/FH 10;6-LB+LX0(JL?"PS$K$:/VI&X
M(;X6J;.[?_?]58&MOI4@&A:/.'#;.-G,%6.B][;*L#X0U8"P4&\'4*+Q F^_
MDR?#N ]:>089IR&L>91Z.OB\7PD_4;_FEXG;A.4XQD (D8.*-:JQ$0]L/5((
MACJ;:;;91)TW(^S-5#)Q7(-HE)^NW!7_("6O#GK&>HBW(+E0J#HJ,4X\6(".
M\MY6GFLJT@\#6*%=G,$9PQ"0#+!@4_8PQJ$'QH:A'BK&"ZIA1TQ6+=;QE9J#
M!@;\B&,,0-*SOJL;A[%)):A4**^7JXPX&-4MXIR6[*"W?(^Z9, 02\IJ,@J/
MW7(+5$H._T:M^F['/=F6O]F0&S;SNV?#&;Y7I5Y@-R9K,63VHF(,)8?%*E.X
M[S7'811YM)NXSSB[EN.*\B0L*'<7*,C' 0DQ3$*8AC)@_V36C7S 8ML#DVL4
M]0(M-.9=(ID@(JO"^ D?.\H^ATOF[XI?2+O(,)H1'9*W#CHF?P'>,1!B3HY*
ML&*7MKLRPVY#0M"2([<.^W=3MU.;DG"A!(L.81,D 0\!,,@U.[KKTZ!!%# W
M0YB^O.'R;Y0K=W,&4OFYM>"M^4AG"]T4M]YDZ(^WI9PL7?UJT;.1  LQ:T3%
M&X#!F%+06=U75K5F!#V6-' IG7>$&\&MB:YTW;?.:^%2A6E^AFDS65OWV&74
M;-RRA%'2#N1&,X4"0V*.JUKY(_8N.ZR3X-Z:R9=K!REB !.J.'^>%0VZ[EV7
MY0LNEHWJ::--!]:.-FK5#3%--H#Q?%!Y[\1!U(YF-#%KJWY$NC+;329];*H\
ME\$')=4KCI2Z!$W.,1?(B #1RM\ E)B,557O1"Y'P+@V1&^'@=O@:W9R#J%!
M\N/8(QN CD5076MG][0V.40<=O( -U[9L@+7?B.8%GMZ9XU4K46I?VSC2&;J
ML(+'5B;93X$4X_Z.A#^C!6]CGF W(K&)1C%,&;*B<1 MUK0>6YS!P0@."/C/
M2VV*HIGG.*C#N'=%\IPU^LT@3#X!1T<J;3]E6"5>\"&12ZH!MO@1*!_$4O0N
M$NUBF>EE*]XE$M (F:HK@5#E%IQR-477FQ$6>V<;=O8=LB1C@L;Z^/"&N]0(
MDK]\A-BHM,'/&3:,Z:(K4BF!79:* [6.?C)+;2,E>6=CMP6WR>Z:$'Q<ILAZ
MP&!+>,<%J2\%$]VV)K+HX5B0S\9\=I'I,I-&HTNEA/]@Y+E5I>3]KZ@(4Y@Z
MYNZ(98!ZB@G%YQTK1_ Z:U_1MGIX.'@X/3H'.1<;MI6JX@@M;$>"2R;IC0 6
MIXDN"N2/[*J)_5C< ':,4K*;D.%D(9&/&<HJMJG,7)N0? Q((",SF;5_@LZ2
MCR>SQI::"J9KQ/1#>YBH0Q)A5G7^'FA$<G;:P.0T=.83F3B!@2^B3+H$\<[O
M]-1C;;C[$YI!)/E\4,>P<6R F,$,3)QH/T47RJ2S!$W?;;-W8K.>IN.<9^M!
M<98I/NWP9)<U_HN*[. 2 S%R\P[=EBK#;;I1:OH.&1?'=VYPRL7QG6\Y%]><
MA#=;FLMK$]W#]&[VDJ-,? 1:^!]]Y7'!Z>S ,3C"H*Y"BMG'FF]AEB>V^+9B
M @<+.OU),FSHF?'3^<;4Y1@H(;5=&JFP1+R@B-B+6>+DU)W'5J51X\4['3#M
MP1*'"V,?E>L(M&%V@5=*-Z0N<3*PAD-H0.,^H6)KX/Y8-QQJ*][&HV-IJ8HU
MZD>F'IJ,8 $TIL9"N'[*  Y0CIU+WBK[@4D7P6R:'L2C:YYQ>2?P(A.#&10$
M,*)446@3#79N;%H"%7D8Q=(U'D9'-N5S%BZ!$M7+D@K(!6<=Y#/<%O8!, E?
MX&&56LT9\#-'_=U@-\2:@;C&S&Z(<FI*5S/9-E*\D*Q16Z) ]/3FACODX;,R
MF6M.SB7O VJMK.\4V1+YI.F6//Y*W;)#<(8-0VM7\Y*.H9(+'"1JL1GL".C)
MOP+;KR_&36B_N:>C7#8JI,1"VC8+XAZ6A+?LM(6?YDC@ G@U3!..G/KUN!;M
M;>)VTCM*?F,030-/)FCP< W2<!%,2^R1"*M1+$I(1IV% [C9;&VR\>,TWF!E
M2%]P9=KYV@LW.#MN#  \W@W_PNZV\C$GGTL_1FFTK$ Z\>$L:L(.;Y:T6]L8
MD_@&"FON$K()T6;KM/#M&#H9Y;YCI04?2T90KQW'CM -C7<#6)UN"QWXR?_L
MKL0T=Y2\U.\5GF5(#OM[TQN6;-PO]:<V1_E;D;B=$'3MOV$KQ)!#CI8Q:@-[
M:>E>4#C>Y[$(W70A"*B^E!;$BE8H&@Q:&]M%B:RQMXWYALM*MYE!)LU]:O;[
M>QY],]B.5'HT)GI6^;*8@/M\_<._8+OM$O.%MF\NM+ &+R8L?<&W]&P8+0"@
M1#<Z+#LEKYOS;G*5 WK<:%OQ/48J72G2-*VXXH^%"V&[,L)5"C4P7T![J1+<
M',Z$F&GY2\_817 '] ^QTJ2<ZAA&I9THW6FI"'")>(W5>5S1/"BLKYN@Q;I!
M?/*-<-(LYG..!9:=YZDEKMYPU^J16QVJ1)^Z+OA:6RV2IK+9;OG7T74/D+WK
MJ?=*W=A(V,AM1^^N9AQ5 B#CBX7JH0D%@S8WUT32U(/ \!EQ\.O&=#3 J];:
M3XH>A->NX];K4J0H42C=A5XC,PD/JDE@BMCS;_LY(OTJ[K_H=70A!6JL%PTV
MJ&4G]E(UYT&Z0K;F^?(E0?:.4HGU?VMF73+E2UH!!KZH5U"6/.,;RB%GA!\^
M2GZG9V0/)$^+=H [%:7;M*"&PE,H8$JO8E\VR&:(>7CR$;\5>/.66YZ%,<P@
M41X95AA1,Z<"2JAN\GZ)MEBNI#?K8*FIC4%YU+%%_Z'#P11H%A>1=U_.R$)&
MJ"FE7]AT*-W)$N7=B5)S&;=.1K5Q-;9D)N09IMIFJ'U;Q_ESPM*=4[VG$2+H
MJ%TUNK8*,)7N*_Y;K R*B9"M.415##KB*5O2$!Q+Y&@W'GDT/'HEP2HS:#2@
MRR>F$\HUVH9<*2QU?*;CP2 H&RQK:G<.IA])E+CT]3R2*Z0)88P$\[-H^F9&
ML&V'7U./]YWDRRZNW>.;[-H]_N;:_0+(>..Y?W_MU:330-MG5>D%Z^^$,\@J
MATN^GK*;Q(7'V>6<_)B7&87HRE*=,VQCD(>]FQ^ K/5*_*U8*5VP2!EIPT9)
MC9C F5M+AX7$V#IB62]]X5#"XM=05&>MZ^^G&>^UWKZL-%)<R/I04FD]D]P0
ML@?-O,1E9@K2IG88!KL BBS\,G$3=N>\!)A1VYDC<,HG>\%NG'S9>#%_N/87
M\W=TTC:FYP/[;!MC6CLZ%IQB2R**Z VM$6DJ1*@9GKY#JK75I9%P<&CK!A)4
M%E16)/&.OD<>(J\$9"29S#@:.+?(NCJF[ZHL2=*@^!.!>VOD+J2A X)]\I0:
M,6M)0':Q)\)B-\?S:IA+8;0!DTZ"_?6&XZE\NSW^[3F^\[FOSR3:L5C[6.3+
MZ9L$/T]@YH01M+1MX(Q[*@"8LCF@:.+1_1CGQ&U/*+]4286^SO!^2=\A-C38
MJ.7P##MC&W6.N692/I K$ /D"T3\JI2B.JA'4=:4+M*!L21&7IFAQ[DHR"%*
MP<N1H ^GN$[FM88AN8%10XE6:,D20#T!&RL[GZSS?+#/%AA=.^6TU0N0[:_I
MX4]8?O=5W)OC:WAOWE"NZ#@VG\1&SIML/'_9"Y]%86YG#U>(W(BW HM0N+97
MG!O[>R8"3,48W'):*HWP_[1QR W;*Q#"5HX)='!2[Q7W+O1RYQB/FB[Z[3"5
MW($Y49)LNY"(5-T,,YTMGGC?6&&VM3#-AEF^D;Y/^G>O(>ECN4R)=@;P[=>^
M+W)3%84?*$3]9Y"$;"2!R2G';B<<I>&O83?%8=G:EC1W+F7*#N-D^Y#=^[GV
M5';02"@KADMUK:E]7&17MA=66_@(:-*3K[(P4,$$))=8K$$/[P%=HH4B!S*Z
M)#S0"4)VK<?!:W&G, /X*'EM@C91-!]7C @$U%.<W*-5;7(X>+LYLWL$;\P&
MZ"P$EG'.V2%P-2:Z&[HC)[)AN<,7._<LSS$-X/WFP&-HNS4ATV)N!IW/1:U-
MAS>W&&KI'I&J*5&P)K#*&E\K]UZV25/?N%/ G>Y=0^Z$"NW<<V;@# S!B:/&
M=^@/J[E*E5TH"9QSV"$*5*2V>Z<NH_Z=\(LTRND>,+[8\/(\_J.,S:=;]OCO
MF-WBA4H,L+3)VC!EJ%$J2T?9?IC#,:Z3P%;:Z68S$VC9/F,XINU3_G:U_*MU
M_[-=K5%W)V%#VK,:C0W[_:4YMX%>RKR0FQ/?)B(<M[<GT<98XQB$[3HA6D%M
M;WNT"Q6A</E%<;5TN'%-FWW[- 7*/0>Z-C_9XD+S"]?K'-7?U()H2N]9;^++
MU!F&KB8<GBML4DC#H2R'IQ.FC;1@T!*Z$RQ<XL1>;AW(4/9%&=F.GB-L^E5A
M7(5L1.J"V;)U,8*)&M9EQ&AG^!LWF0/7/9ITK@(HM.B7+-R[^C"A5D9F1CX,
M!,7[J%B#I/;D#K!/P4<3GO2%!VXXZA>!;7+L7E%7'7.^MN,.^^3(% FY+N:7
M@052>LRN$%L\9K4WS^;8)8AX]R8'$>]^"R)>?S(^?G!T%5$%A%PW[,PBK@?\
M2A)/B.FQ-Y(9G)(^-Q2A,ZQ*4U*=QZR&J:V5I+3&[,J74Q<J3J:\<6SK^.&G
M/6\XZ)^I 1U5 [S,+C>GO+GT2--<CVHVN(>=M'WCUBBHS+3FF+$1G!$X[SK)
M"GJNRHQ!\TW&TCE%D_;W1-:ZMN36!J6!0.Y6N5Z5;.R2[*5!;QPM_.NJ[OYK
MOWX']GB8$3GBP'!%JC:;,3DPW0JX=2$;BOSO%(D#%+5\D:%KAK(,P:Q$"D.I
M:!U(-N?VD%0M_%;=^&5/R"_*TI"70^!I;%IB7%I?>Q4M\$PO7F92=\G_Q>')
M02IU9;U.J)=7E8''J)TW2D+HPS8FMK[)0["S'])SZSCRLB 764&(7%6R HWA
MYI'W]U=%WL^"W.^W2F %WA .X(C?UJ.6#<6+U)\769DQHJ)X^U#G=PRN:[)F
M3<#2ZR SW;-PTL3VWTAM41'C<4Q62XVUK@*"FRM-0!0,'\:)D'&(1DH%HE+(
MSD>"=*0LWSU!F-4J2WY16=DMTN1%E1\E_F8GT5ZGIOD6W9U(I>!L>HV7#3^+
MB:D'4I7H&(Q@-QIC[<;=D1\^N3KPTB*0 >NOP""0/%G@?L^X=WIR2B 1=%%N
MRG[O4I"=71/HKQ'GE3O4Q#M3DR(TX%K IUQ^LV%/814..3#O$0_T_)H/)BJQ
M**>9<W4L+I#%20S0R%T1 PE,$Q<9(&TX+AK4Y1QX36_X4U&7&PM*Z%QU8'7(
M6U@EE2_P5S)/ ]2!&R3B'T&7)$9G5GWW^SL_&RT#D?,/'7P@IKMS0 Z3 -&B
M!QLZI5HYCR<S3\UQ 5WV 2$B:ZGQ,Y^X_\,//_B?2 [P7VZQI_SV6?;!7Z^7
M ADGPV-Q.3%61IND#'WL 25!MJ"6E3\K^\GE%ID>>-U,Z; \[D!2J7RJ(ON-
M^F,Q*J&,1@>"ZM0'(-'_3"0"4(SM%FZ-*1?^D5I'F4&HO:73 8W7E>8?3_\@
M\[:-@%E&""6E*FWJ)64I=LZ&;49^VWC4MAXA82%>J>0K@>=@EJ5Y!<Z8RENL
M^<.@2"%9[.^YDPVG_E;:=(W-GD]"73@W'Q[J>4VGL90F=Z!:4N/MBA"4J"[;
M3X3%F8580ZP2,-@06&#UDJA5>?%1?ZIE:3HJVN*2A3Y?X XP]T7((BIWJ)3=
M3B*#?NEAP>/12O=V_YLF92DW:G6$208T;48P-J+#=>8ET#B'J93'MI,U@W2*
M*TP^)*1J1XO4C"JU+HES*N%OQLENJ!S:QEAHS>"Z3%*O3U:B$D6LPNWS#2DL
MW$7ZSCZW](W%+IH0?JFME[LG('L>&@+":@H&Y; H'@7(N:KH$F1]H05;O>7J
M>"&T(O,C$OR;CODI]_4S-*6YD(KEP-+T7C<R0$*6OI6*-8"8"NR56GDB__A[
MF_K?A2M&<)9M2V[KR563P&P8V:(U+V;2]!UWP<N[0J?"A2YZY%7G3=VOO&I'
M":@0?.%"2N4R5R$02T9@?]B^$%@([P4Y&+"6_;PBA^3'':G)"Z'S"+88=T?V
M&(T7VMQ1S\H,[#[N<"K 9Z,!P^C\9A;S;;?9[N_1=,>.W<WN&[,QS";_>IC-
M-(6ZDQ=*-,@NZ!4 "9KW@J6.Z1ZFZ2319H& * @#@;#H*-;@HR9<*5F:@W3A
M08Y5)PGX:/AGK4G%'L<,\=\\VM\;\J(=-L1JP:W-!O,4&BQ)%J=+?/TR)^0%
MB)^5: ;^MM6P48$1_BK2X5)7W3WOFTJW$UB\'MX.848F]4I7.*P'#LZHXEPM
M-8":&2[/=/\TID>\1CH*F2;'L\\1$GZ>R7'[9".+B_97NK#&-#5#\50AWS:5
M[)+CEI=]2\4H*ZL34;K$C>)"NP2I[]WD(/6];T'J:TO"XJZ[>^>3^RB?,6 #
M<;;_Y95\/DI^JALP']]1,WB+/WC"AA9A_ [#SH:]_LB]*II&7=0Y\5 PNY;:
M=] (2PH@EDQC9V=>&GN5ZE,="CIQ0_*B#<$VK+&Y4!G8\,#I5,/ %FBK=NB8
M<2:]3=5V=:]QNEA8!QMB*'$Q*WI1B-O"@^3.Z@V@&K=(,?Z_L(2.8@+>#DG(
MS)BRDL.M*U1N67;XZ.>C$Q 3%Q;>%%("9;Q1W'6#K?P&KB(ZU,((1%RJF@:S
MRSTRH2-"<\(E-YM.Q]+)W6S3]%1%\5@*^!55'C.RNJD7EI&,P.3*1),AQP57
M^WM!/E?DS#P(O)DDTA&^<8A9?@C;D7_T=K!-0E!/O!?DO3#3%AIP6][:$Y!P
MIY794OU(AJ3L*@EJ;]F&[JVM:H8>VUM0: ^*CUL.8Q&2'Y K&_X0BS2XX?"5
M(./?U#AP6L):SO%"(3"(Z50Q30':MF[U-LGK.V]@XD><@>,3,1"ADY_<W[/8
M.1Z:/'5,\^#+Y\CV'K'767W<-H8HH*2+82, J@5@</8_^N)\R?6*VVZ(GRAB
MN"5.2BZY%-C2Q>8B2I]1B=6J;=ZG^;# /%ID,!M]MVFH4JB.L8R%G-,('K>Q
M\"6]Q-:@!:7*'$EDN$^L@>%:_8A'\/?W]VYZJ?S=/UV6^"@9-I*\FB 8J@L]
M:JEXON.07H8\J0A5TIBP#+A?SMB%GGLCI(D!4&0Y?HDA%O1CF;>#.EX/6XYS
M.=BS@D8;$!_>MD<4)#+\Q'[&HF.(8>W%J^I*65N0(N?&MOX*R<\T O__W[WX
M^=7)V6]O3Y,W)S^?)C^]?OGR]>_O_L\7W7_<-ES?Q<Z[?Y/MO/O?[+R/(,[1
MN_O7/AU=^A>ODM]?G+TZ??<N^?V7T[>GKW]*A\9":W)Y.'(H)1'%6/U'ZB "
M'1]EZ-*L)(YL,XAC]Q_\K D<;K3.(36IQ9U?#)8&@9/.A$BR60T27[*6/SDS
MW<(WSTZ>OCQ-GIV^?/GFY/GS%Z]^_J_O[GQ'/[][<_+,_/PG9R(W=GA?,;>A
MZ!8XUIU_ ,&?O0TN[J5"#>E'X!IE\0C4Y 8;#I:&MF#044'QW1-<S_/DV6N<
M^ZO_^N[N=Y.C;F473ZGZZM<W+U__^_0MBN\?']]^ZJ[]V?,G^*GI2?OS*]5\
M.W]ZZHYF^)U=EC2Q)Q^QSM/1=:).<_;6/Z._<"!ND>$.#K<K?G!D"T8_&;R'
M$V<NF7RB^9^\.WM[\NHD^>7TY.79+\FO\.^?3W\]?766)B]>/3NZNG4AK&<!
M"MS3K%W45[6Z+_%TY#5A*/> G3Q=_V@HU_U]LP9B&=+]AS# [?9V\K2!_0:3
M\)U>;ML.^_+=?TQN(6CMG;K5KC+4JJKZLLG&5V7'PGF\H[(5LYCD[_C?1^S8
MIMG?O\?;^'&SOBH:#PZ%?_,1QWN=J'UD)1&442)(1G_KJN _J$=$BHM51SQ;
MXUKH&]^8YB:N)%OU #8*L93_ B^]#T.<K!I=)O?3Y.Z=N_<_"R>-%_(IV67\
MOT_%/B=VSC_\T2MWI;;"U7QE)S?$@T?)ZQ6Y:W],7B*0W(WS13SX:%_$5?L%
MME#+[:>OG_^;9,,O9[^^?/)_ 5!+ 0(4 Q0    ( ."EA%C4+*(6+@,  .8+
M   1              "  0    !A;65H+3(P,C0P-# R+GAS9%!+ 0(4 Q0
M   ( ."EA%BA1)H?_0H  ("&   5              "  5T#  !A;65H+3(P
M,C0P-# R7VQA8BYX;6Q02P$"% ,4    " #@I818,/]4X5@'  #75P  %0
M            @ &-#@  86UE:"TR,#(T,#0P,E]P<F4N>&UL4$L! A0#%
M  @ X*6$6!VX!C"R'0  TJ(  !(              ( !&!8  '1M,C0Q,#DS
M.&0Q7SAK+FAT;5!+ 0(4 Q0    ( ."EA%C,_ =[4DP   &/ 0 6
M      "  ?HS  !T;3(T,3 Y,SAD,5]E>#$P+3$N:'1M4$L! A0#%     @
MX*6$6!A6]#>]30  @J ! !8              ( !@(   '1M,C0Q,#DS.&0Q
A7V5X,3 M,BYH=&U02P4&      8 !@"- 0  <<X

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm2410938d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ameh-20240402.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2024-04-02</startDate>
            <endDate>2024-04-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-02" id="Fact000004">0001083446</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-04-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-04-02" id="Fact000010">2024-04-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-02" id="Fact000011">ASTRANA HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-04-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-04-02" id="Fact000013">001-37392</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-04-02" id="Fact000014">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-02" id="Fact000015">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-04-02" id="Fact000016">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-02" id="Fact000017">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-02" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-02" id="Fact000019">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-02" id="Fact000020">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-02" id="Fact000021">282-0288</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-04-02" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-04-02" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-04-02" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-04-02" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-04-02" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-04-02" id="Fact000027">ASTH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-04-02" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-02" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
